Synthetic peptide 41 54 human bcl-2 protein
peptide corr. to 20 34 the 26 kDa human bcl-2 protein
Synthetic peptide 201 216 the bcl-x protein.
Synthetic peptide corr to 41 54 human bcl-2
synthetic peptide sequence comprising 51 54 bcl-2 protein.
synthetic peptide corr. to GAAPAPG IFSSQPG, 41 54 human bcl-2 protein
synthetic peptide 7 18 , Cys-QSNRE LVVDFLS, of human Bcl-X protein
calmodulin-binding domain of myosin lightchain kinase fused to 42 142 chicken Bcl-X
A synthetic peptide 41 54 human Bcl-2, GAAPAPG IFSSQPG-Cys
synthetic peptide corr. to 61 76 mouse Bcl-2Cys-VHREMAAR TSPLRPLV
peptide corr. to 20 34 human Bcl-2 protein
recombinant peptide sequence, 51 54 bcl-2
recombinant 51 54 bcl-2
synthetic peptide corr. to 687 706 , the carboxy terminus of bcl-6of human origin.
synthetic peptide corr. to 41 54 the bcl-2 protein
Human Bcl-w synthetic peptide ( 16 29 )with an additional cysteine residue
Human Bcl-2 synthetic peptide ( 41 54 ) with an additional cysteine residue
Human Bcl-2 synthetic peptide ( 16 29 )with an additional cysteine residue
61 76 the human Bcl-2 peptide coupled to KLH
41 54 the Bcl-2 protein
41 54 , GAAPAPG IFSSQPG, of human bcl-2a protein
41 54 bcl-2 protein
synthetic peptide corr. to 41 54 bcl-2 protein
synthetic peptide corr. to 3 14 human bcl-xl
synthetic peptide corr. to 3 14 human bcl-xl
synthetic peptide corr. to 61 76 mouse bcl-2
synthetic peptide corr. to 5 19 human bcl-10, N-term
61 76 the mouse bcl-2 protein.
41 54 the mouse bcl-2alpha protein.
3 14 the human bcl-xL protein.
150 169 the Bcl-X protein
aa. 201 213 the bcl-X protein
aa. 20 34 the bcl-2 protein
120 133 , AYQSFE QDTFVEL spanning the epitope created as a result of alternate splicing.
298 312 [TKYLKENF SPWIQQH] of the human BCL peptide
71 83 [SWPCRNS QSSEKA] of the human BCL peptide
fragment corresponding to 49 179 human bcl-2 protein
synthetic peptide corr. to 68 86 mouse bcl-2, highly conserved between mouse and rat
synthetic peptide corr. to 68 86 mouse bcl-2, highly conserved between mouse and rat
synthetic peptide of 41 54 aa sequence of human Bcl-2
synthetic peptide corr. to 120 133 Bcl-XS
synthetic peptide corr. to 41 54 Bcl-2
synthetic peptide corresponding to 41 54 the Bcl-2 protein, conjugated to thyroglobulin
calmodulin-binding domain of myosin light chain kinase fused to 42 142 chicken Bcl-X. This sequence shares 75% homology with amino acids 46-146 of human, mouse and rat Bcl-X.
synthetic peptide corresponding to 2 20 , N terminal of human Bcl-X
synthetic peptide corresponding to 3 14 ,shared by murine and human Bcl-XL,conj. to KLH
synthetic peptide corresponding to 61 76 mouse Bcl-2, conj. to KLH
aa. 41 54 GAAPAPG IFSSQPG of human Bcl-2
aa. 41 54 GAAPAPG IFSSQPG of mouse Bcl-2
aa. 42 142 chickenBcl-X; recognizes both Bcl-XL and Bcl-XS
synthetic peptide corr. to 41 54 the human Bcl-2 protein
61 76 amino acid sequence of murine Bcl-2, conjugated to KLH
synthetic peptide corr. to 41 54 (GAAPAPG IFSSQPG) of the human Bcl-2 protein; not conserved between human and mouse
N-terminal peptide, 3 14 , common to human and mouse Bcl-XL and Bcl-XS
synthetic peptide containing 61 76 human Bcl-2 protein (differs from mouse)
synthetic peptide corr. to 41 54 (GAAPAPG IFSSQPG) of the human Bcl-2 protein; not conserved between human and mouse
synthetic peptide corr. to 46 66 the human Bcl-X protein; this region lacks a homolog with other membbers of the Bcl-2 family
synthetic peptide corr. to 68 86 the mouse Bcl-2 protein, highly conserved between rat and mouse
synthetic peptide corr. to 41 54 (GAAPAPG IFSSQPG) of the human Bcl-2 protein; not conserved between human and mouse
synthetic peptide containing 61 76 human Bcl-2 protein (differs from mouse)
synthetic peptide corr. to 68 86 the mouse Bcl-2 protein, highly conserved between rat and mouse
synthetic peptide corr. to 41 54 (GAAPAPG IFSSQPG) of the human Bcl-2 protein; not conserved between human and mouse
synthetic peptide corr. to 41 54 (GAAPAPG IFSSQPG) of the human Bcl-2 protein; not conserved between human and mouse; second antibody is a control, unknown specificity
synthetic peptide corr. to 46 66 the human Bcl-X protein; this region lacks a homolog with other membbers of the Bcl-2
N-terminal peptide, 3 14 , common to human and mouse Bcl-XL and Bcl-XS
Synthetic peptide corr. to 61 76 the mouse Bcl-2 sequence
synthetic peptide corr. to 41 54 the human Bcl-2 sequence
Synthetic peptide corr. to 3 14 the human Bcl-xL sequence; this epitope also present in Bcl-xS
recombinant mouse Bcl-2, 1 208 , lacking the C-term mitochondrial targeting sequence
KLH coupled, synthetic peptide corr. to 32 51 human and mouse Bcl-w
KLH coupled, synthetic peptide corr. to 4 22 human and mouse Bcl-2
purified, recombinant human Bcl-w 1 172 with 6 histidines at the C-terminus
purified, E. Coli-derived recombinant mouse Bcl-2 related protein A1, 1 152
18 233 rat Bcl-XL including membrane localization hydrphobic tail
18 233 rat Bcl-XL
49 179 human Bcl-2
18 233 human Bcl-XL
synthetic peptide of the LDL receptor binding region, 140 159
human apolipoprotein E2, AA 154 172 (Arg158-Cys)
synthetic peptide corresponding to partial amino acid 109 119 a.a.) of human apolipoprotein E4
154 172 human Apo E2 (Arg158-Cys)
human Apo E2 (Arg158-Cys) aa. 154 172
a recombinant protein corresponding to 126 191 human apoE
a recombinant protein corresponding to 18 317 at the carboxy terminus of human apoE
19 175 human Apo E
vicinity of 142 147
vicinity of 243 272
synthetic peptide corresponding to 768 781 human or mouse β-Catenin
769 781
epitope between amino acid 683 781
epitope between amino acid 1 70
epitope between amino acid 70 120
mouse recombinant β-Catenin ( 35 50 )
mouse recombinant β-Catenin( 27 37 )
683 781 , Cterminally directed β-Catenin
683 781 , Cterminally directed β-Catenin
1 70 at Nterminus of β-Catenin
1 70 at Nterminus of β-Catenin
70 120 in Exon 3 of β-Catenin
70 120 in Exon 3 of β-Catenin
758 771 , in the carboxy terminus of human β-Catenin
synthetic peptide (PGDSNQL AWFDTDL) corr. to 768 781 human or mouse beta-catenin, conj. to KLH
a 23 kDa protein fragment corresponding to 571 781 mouse β-Catenin
mapping to 764 781 carboxy terminus of the humanβ-Catenin
a recombinant protein corresponding to 680 781 mapping at the carboxy terminus of human β-Catenin
680 781 mapping at the carboxy terminus of human β-Catenin
a peptide corresponding to 768 781 human or mouse β-Catenin
571 781 mouse β-Catenin
571 781 mouse β-Catenin
571 781 mouse β-Catenin
571 781 mouse β-Catenin
29 49 human β-Catenin (consensus GSK3 site)
recombinant protein corr. to 2957 3256 mapping at carboxy terminus of human Ki-67
recombinant protein corr. to 2957 3256 mapping at carboxy terminus of human Ki-67
1547 1742 in the tandem repeats section of human Ki-67
270 282 mouse NFkB p65
human peptide, epitope: 363 376
human peptide, epitope: 501 515
human peptide, epitope: 2 17
human peptide, epitope: 363 376
human peptide, epitope: 501 515
human peptide, epitope: 2 17
recombinant protein corr. to 1 447 , full length Human NFκB p52
recombinant protein corr. to 1 447 , full length Human NFκB p52
a recombinant peptide mapping at 1 286 corr. to the amino terminus of Human NFκB p65
a recombinant peptide mapping at 1 286 corr. to the amino terminus of Human NFκB p65
a recombinant peptide mapping corr. to 120 239 at the amino terminus of Human NFκB p50
a recombinant peptide mapping corr. to 120 239 at the amino terminus of Human NFκB p50
mapping corr. to 1 447 , full length Human NFκB p52
mapping corr. to 1 447 , full length Human NFκB p52
mapping corr. to 1 447 , full length Human NFκB p52
recombinant protein corr. to 1 286 at the amino erminus of Human NFκB p65
recombinant protein corr. to 1 286 at the amino erminus of Human NFκB p65
recombinant protein corr. to 1 286 at the amino erminus of Human NFκB p65
recombinant protein corr. to 120 239 at the amino terminus of Human NFκB
recombinant protein corr. to 120 239 at the amino terminus of Human NFκB
epitope corr. to 350 363 mapping at the NLS region of human NFκB p50
epitope corr. to 338 357 mapping at the C-terminus of human NFκB p50
epitope corr. to 120 239 mapping at the amino terminus of human NFκB p50
epitope corr. to 120 239 mapping at the amino terminus of human NFκB p50
epitope corr. to 298 324 mapping within a conserved epitope of mouse NFκB p50 (identical to human)
epitope corr. to 531 550 mapping at the C-terminus of human NFκB p65
epitope corr. to 3 19 mapping within the N-terminus of human NFκB p65
epitope corr. to 4 21 mapping at the N-terminus of mouse NFκB p50
a recombinant peptide mapping at 1 286 corr. to the amino terminus of Human NFκB p65
recombinant protein corr. to 1 447 , full length Human NFκB p52
a recombinant peptide mapping corr. to 120 239 at the amino terminus of Human NFκB p50
mapping corr. to 1 447 , full length Human NFκB p52
recombinant protein corr. to 1 286 at the amino erminus of Human NFκB p65
recombinant protein corr. to 120 239 at the amino terminus of Human NFκB
human p65, 12 317 , expressed in E. Coli
a 23 residue synthetic peptide corr. to 529 551 human NFκB p65, coupled to KLH; identical to mouse sequence over this range
mouse NFκB p50 synthetic peptide corr. to 4 21 , with cysteine (C) residue added and peptide coupled to KLH
generated from 18 233 human NFκB
generated from 18 233 human NFκB
GST-fusion protein corr. to 1 444 human NFκB p52 subunit
synthetic peptide (CYNPLGLD GIIYDDFK) contained within 4 19 human NFκB p52 subunit,conj. to KLH
KLH conj. synthetic peptide (MAEDDPY LGRPE-C) corr. 1 12 NFκB p50 subunit,with a C-terminal cysteine
recombinant protein derived from 164 363 human NF-kB p50 protein
peptide comprising IkB Kinase β 743 756 C-terminal, conj. to KLH
931 947 on C-terminal of human NFkB Inducing Kinase (NIK)
synthetic peptide corr. to 712 727 human NAK/TBK1
recombinant protein derived from 164 363 human NF-kB p50 protein
peptide corresponding to 931 947 human NIK
peptide corresponding to GST-RANK intracellular domain, 235 616
a recombinant peptide mapping at 1 286 corr. to the amino terminus of Human NFκB p65
recombinant protein corr. to 1 286 at the amino erminus of Human NFκB p65
recombinant protein corr. to 120 239 at the amino terminus of Human NFκB
recombinant protein corr. to 120 239 at the amino terminus of Human NFκB
synthetic peptide corr. to 526 539 human NF-kB (p65) protein.
peptide corr. to 931 947 human NIK
synthetic peptide corr. to 712 727 human NAK/TBK1
ChAT 168 189 ) coupled to Keyhole Limpet Hemocyanin with glutaraldehyde
GST fusion protein, corresponding to 227 353 human m1. Epitope located in the 3rd intracellular loop
GST fusion protein, corresponding to 225 356 human m2. Epitope located in the 3rd intracellular loop
recombinant protein corresponding to 364 474 mapping near the carboxy terminus of alpha2 subunit of the human nicotinic acetylcholine receptor
recombinant protein corresponding to 346 445 mapping near the carboxy terminus of alpha3 subunit of the human nicotinic acetylcholine receptor
recombinant protein corresponding to 342 474 mapping near the carboxy terminus of alpha4 subunit of the human nicotinic acetylcholine receptor
recombinant protein corresponding to 356 456 mapping at the carboxy terminus of the beta 1 subunit of the human nicotinic acetylcholine receptor
recombinant protein corresponding to 342 433 mapping at the carboxy terminus of the beta 2 subunit of the human nicotinic acetylcholine receptor
peptide analogue of the carboxyl terminal of the nicotinic alpha 5 receptor ( 460 468 ) attached to a carrier protein
peptide analogue of the carboxyl terminal of the muscarinic M2 receptor ( 457 466 ) attached to a carrier protein
peptide analogue of the carboxyl terminal of the muscarinic M3 receptor ( 580 589 ) attached to a carrier protein
peptide analogue of the carboxyl terminal of the nicotinic alpha 3 receptor ( 496 503 ) attached to a carrier protein
peptide analogue of the carboxyl terminal of the nicotinic beta 3 receptor ( 450 458 ) attached to a carrier protein
peptide analogue of the carboxyl terminal of the nicotinic alpha 3 receptor ( 496 503 ) attached to a carrier protein
peptide analogue of the carboxyl terminal of the nicotinic alpha 7 receptor ( 493 502 ) attached to a carrier protein
peptide analogue of the carboxyl terminal of the nicotinic alpha 4 receptor ( 620 627 ) attached to a carrier protein
peptide analogue of the carboxyl terminal of the muscarinic M1 receptor ( 451 460 ) attached to a carrier protein
peptide analogue of the carboxyl terminal of the nicotinic beta 2 receptor ( 493 502 ) attached to a carrier protein
peptide analogue of the carboxyl terminal of the muscarinic M1 receptor ( 451 460 ) attached to a carrier protein
peptide analogue of the carboxyl terminal of the muscarinic M2 receptor ( 457 466 ) attached to a carrier protein
peptide analogue of the carboxyl terminal of the muscarinic M3 receptor ( 580 589 ) attached to a carrier protein
peptide analogue of the carboxyl terminal of the muscarinic M4 receptor ( 469 478 ) attached to a carrier protein
peptide analogue of the carboxyl terminal of the muscarinic M5 receptor ( 519 531 ) attached to a carrier protein
peptide analogue of the carboxyl terminal of the muscarinic M5 receptor ( 519 531 ) attached to a carrier protein
Synthetic peptide, M1 451 460 ), covalently attached to a carrier protein
Synthetic peptide, M2 457 466 ), covalently attached to a carrier protein
Synthetic peptide, M3 580 589 ), covalently attached to a carrier protein
Synthetic peptide, M4 469 478 ), covalently attached to a carrier protein
Synthetic peptide, M5 519 531 ), covalently attached to a carrier protein
part of the i3 intracellular loop of human M1 muscarinic acetylcholine receptor ( 227 353 )
part of the i3 intracellular loop of human M2 muscarinic acetylcholine receptor ( 225 356 )
synthetic peptide corresponding to 568 588 the rat nicotinic AChR α4 protein.
GST fusion protein and part of i3 intercellular loop of human m1 muscarinic acetylcholine receptor ( 227 353 )
GST fusion protein and part of i3 intercellular loop of human m2 muscarinic acetylcholine receptor ( 225 356 )
GST fusion protein, corresponding to 227 353 human m1. Epitope located in the 3rd intracellular loop
GST fusion protein, corresponding to 225 356 human m2. Epitope located in the 3rd intracellular loop
part of the i3 intracellular loop of human M1 muscarinic acetylcholine receptor ( 227 353 )
part of the i3 intracellular loop of human M2 muscarinic acetylcholine receptor ( 225 356 )
fusion protein containing 269 320 from human m1 AChR
a 23.3kDa fragment corresponding to 411 609 the human AChE protein
epitope corresponding to 475 482 mapping at the carboxy terminus of the alpha 1subunit of the human nicotinic acetylcholine receptor precursor
protein fragment corresponding to 332 457 from rat ACHRα
epitope corresponding to 446 464 mapping at the carboxy terminus of the α3subunit of human nicotinic acetylcholine receptor precursor
epitope corresponding to 460 479 mapping at the carboxy terminus of the α3subunit of human nicotinic acetylcholine receptor precursor
epitope corresponding to 483 501 mapping at the carboxy terminus of the β2 subunit of human nicotinic acetylcholine receptor precursor
epitope corresponding to 385 404 mapping at the carboxy terminus of the β3 subunit of human nicotinic acetylcholine receptor precursor
epitope corresponding to 482 501 mapping at the carboxy terminus of the β subunit of human nicotinic acetylcholine receptor precursor
protein fragment corresponding to 62 224 from rat AChR beta
epitope corresponding to 498 517 mapping at the carboxy terminus of the δ subunit of human nicotinic acetylcholine receptor precursor
epitope corresponding to 474 493 mapping at the carboxy terminus of the ε subunit of human nicotinic acetylcholine receptor precursor
epitope corresponding to 500 517 mapping at the carboxy terminus of the γ subunit of human nicotinic acetylcholine receptor precursor
epitope corresponding to 450 469 mapping at the carboxy terminus of the α2 subunit of rat nicotinic acetylcholine receptor precursor
epitope corresponding to 573 592 mapping at the carboxy terminus of the α4 subunit of rat nicotinic acetylcholine receptor precursor
epitope corresponding to 501 520 mapping at the carboxy terminus of the δ subunit of mouse nicotinic acetylcholine receptor precursor
epitope corresponding to 475 494 mapping at the carboxy terminus of the ε subunit of mouse nicotinic acetylcholine receptor precursor
recombinant protein corresponding to 364 474 mapping near the carboxy terminus of alpha2 subunit of the nicotinic acetylcholine receptor of human origin
recombinant protein corresponding to 346 445 mapping near the carboxy terminus of alpha3 subunit of the nicotinic acetylcholine receptor of human origin
recombinant protein corresponding to 342 474 mapping near the carboxy terminus of alpha4 subunit of the nicotinic acetylcholine receptor of human origin
recombinant protein corresponding to 481 614 mapping at the carboxy terminus of acetylcholine esterase (AchE) of human origin.
recombinant protein corresponding to 231 350 mapping within an internal region of muscarinic acetylcholine receptor M1 of human origin
recombinant protein corresponding to 211 380 mapping within an internal region of muscarinic acetylcholine receptor M2 of human origin
recombinant protein corresponding to 271 480 mapping within an internal region of muscarinic acetylcholine receptor M3 of human origin
recombinant protein corresponding to 220 394 mapping within an internal region of muscarinic acetylcholine receptor M4 of human origin
recombinant protein corresponding to 230 426 mapping within an internal region of muscarinic acetylcholine receptor M5 of human origin
recombinant protein corresponding to 356 456 mapping at the carboxy terminus of the beta 1 subunit of the nicotinic acetylcholine receptor of human origin
recombinant protein corresponding to 342 433 mapping at the carboxy terminus of the beta 2 subunit of the nicotinic acetylcholine receptor of human origin
411 609 at the C terminal of human AChE
62 224 near the N terminal of rat nicotinic AChRβ
332 457 at the C terminal of rat nicotinic AChRα
peptide corresponding to 362 380 human RAGE
peptide corresponding to 42 59 human RAGE
synthetic peptide corresponding to 42 59 human RAGE
synthetic peptide corr. to 42 59 human RAGE
Peptide corresponding to 42 59 human RAGE
synthetic peptide corr. to 42 59 human RAGE
synthetic peptide corr. to 385 399 human RAGE
1 300 mapping at the amino terminus of human RAGE
Peptide corresponding to 42 59 human RAGE
synthetic peptides corresponding to 2 12 in α-syn
synthetic peptides corresponding to 104 119 in α-syn
116 131 the human αsynuclein coupled to diphtheria toxoid with a cysteine residue attached to the N-terminal of the peptide
11 26 the human α,β and γ synuclein protein residue
synthetic 116 131
on the C-terminus of human alpha synuclein peptide
116 131 from human alpha-synuclein
synthetic peptide corresponding to residues [Cys], 117 131 human α-synuclein
Synthetic peptide corresponding to 116 131 humanα-synuclein
recombinant protein corresponding to 1 140 representing fulllength human α-synuclein
epitope = 121 125 human α-synuclein
116 131 on the C-terminus ofhuman synt. αsynuclein
synthetic peptide corresponding to 116 131 C-terminus of human α-synuclein.
immunogen = recombinant human α-synuclein, 121 125
116 131 the human synt. α-synucleinprotein, coupled to KLH
123 140 the C-terminal of the cloned rat α-synuclein
Human α-synuclein 111 131 coupled to KLH
Human α-synuclein 111 131 coupled to KLH
116 131 on the C-terminus ofhuman α-synuclein
116 131 human α-synuclein
108 120 human synthetic α-synuclein
116 131 human syntheticα-synuclein
synthetic peptide corresponding to residues [Cys], 117 131 human α-synuclein
116 131 the human αsynuclein coupled to diphtheria toxoid with a cysteine residue attached to the N-terminal of the peptide
123 140 the C-terminal of the cloned rat α-synuclein
116 131 human synthetic α-synuclein
epitope = 121 125 human α-synuclein
recombinant protein corresponding to 1 140 representing fulllength human α-synuclein
15 123 rat synuclein-1
antibody against Aβ N-terminus ( 1 6 ) used as secondary conjugated antibody
synthetic peptide for C-terminal of human Amyloidβ 1 42 )
synthetic peptide for C-terminal of human Amyloidβ 1 43 )
antibody against Aβ 11 28 ) used as secondary conjugated antibody
antibody against Aβ N-terminus ( 1 6 ) used as secondary conjugated antibody
antibody against Aβ 11 28 ) used as secondary conjugated antibody
amyloid beta, juxtamembrane EC domain, 17 24
7 aa, C-terminus
homologous to Ab[ 1 28 ], Ab[12-28]
1 40 /42
homologous to Ab[1-28], Ab[12-28]
8 aa, C-terminal 1 42
17 42
20 40
37 42
synthetic peptide consisting of 8 17 amyloid beta protein/ amyloid A4, with additional C-terminal cysteine coupled to KLH
synthetic peptide for C-terminal of human Amyloidβ 1 40 )
synthetic peptide corr. to 17 26 Amyloid β peptide
synthetic peptide corr. to 1 14 human Amyloid β protein
synthetic 1 40 human β amyloid
synthetic 1 40 β amyloid coupled to human Thyroglobulin
Aβb[ 1 40 ] coupled to hTg
15 30
1 14 , N-terminal
1 17
1 16
1 16
synthetic Ab[ 1 40 ]
synthetic 1 40
synthetic Amyloid β 1 40 protein
synthetic peptide corr. to 1 16 Amyloid β peptide
N-terminal: Epitope mapping corr. to amino acid 4 10 human Aβ-peptide
C-terminal epitope mapping corr. to amino acid residue 31 40 human Aβ peptide
C-terminal epitope mapping corr. to amino acid 33 42 human Aβ peptide
Aβ 1 42 peptide at the C-terminus
synthetic Abeta peptide [ 1 40 ] without additional carrier
8 17 , synthetic
1 40
synthetic C terminal 8 aa peptide from human beta 1 40
synthetic beta- 1 40 conj. to BSA
synthetic C terminal 8 aa peptide from human beta 1 42
Amyloid Beta 1 40 )
Amyloid Beta 1 40 )
Amyloid Beta 1 40 )
Amyloid Beta 1 40 )
Amyloid Beta 1 40 )
synthetic 1 40 β amyloid coupled to human Thyroglobulin
Aβb[ 1 40 ] coupled to hTg
synthetic peptide of 1 10 mature human amyloidA4/amyloid β; same as aa 653-662 of human APP
synthetic peptide of 8 17 mature amyloidA4/amyloid β; same as aa 660-669 of human APP
synthetic 12 28 , conjugated to BSA
synthetic 25 35 , conjugated to BSA
15 30
synthetic peptide [ 1 40 ]
synthetic peptide [ 1 42 ]
synthetic peptide [ 1 43 ]
672 714 Amyloid A4
synthetic peptide corr. to 17 24 β-amyloid, conjugated to KLH. Epitope at aa 1-12
synthetic peptide corr. to 1 17 β-amyloid, with Glu substituted at position 11, conjugated to KLH. Epitope at aa 1-12
synthetic peptide of approximately 7 10 amino acid residues at the C-terminus of Aβ 43.
synthetic β-amyloid peptide 1 40 ) conjugated to KLH. Epitope at aa 1-12
β-Amyloid [ 1 40 ], corr. to APP(672-711), conj. to BSA
amino acid residue 32 40 beta Amyloid β 1-40 peptide, conj. to KLH
amino acid residue 33 42 beta Amyloid β 1-42 peptide, conj. to KLH
30 aa from bAp[ 1 43 ]
b/A4 1 28
amino acid residue 17 24 beta Amyloid peptide
amino acid residue 17 24 beta Amyloid peptide
amino acid residue 17 24 beta Amyloid peptide
amino acid residue 1 17 beta Amyloid peptide
amino acid residue 1 17 beta Amyloid peptide
amino acid residue 1 17 beta Amyloid peptide
synthetic peptide fragment coupled to a carrier protein;epitope at 1 5
full length amyloid beta 1 42 ; epitope at aa 1-11
amyloid-beta 1 7
amyloid-beta 15 24
amyloid beta 3 9
amyloid beta 7 1 )-42; epitope = aa 11-26
4 10 β-Amyloid
central domain 13 28 Amyloid-beta
653 662 from human amyloid A4 precursor protein and amino acids 1-10 from Abeta (completely conserved in rabbit, pig, bovine,guinea pig, and chicken)
737 751 (G Y E N P T Y K F F E Q M Q N) from human amyloid A4 precursor protein; sequence completely conserved in monkey and chicken
44 63 aa of N-Terminus
human APP, Cys+ 756 770 , C-Terminus
synthetic peptide corresponding to ( 653 662 ) of human APP A4, or aa 1-10 of the 4k Aβ peptide generated by β- and γ-secretases
synthetic peptide corresponding to C-terminal ( 737 751 ) of APP A4, or aa 85-99 of the C99 fragment generated by β-secretase
681 695
synthetic 15-aa peptide near the extracellular, KPI-region 301 316 aa) of human APP770
a synthetic 20-aa peptide near the extracellular, N-terminus 44 63 aa) of human APP695
21-aa peptide within the extracellular 18 38 aa), N-terminus of human APP695
a synthetic 15-aa peptide near the C-terminus of human APP695 606 620 aa)
643 695
synthetic 44 63 , N-terminal
synthetic 681 695 , C-terminal
synthetic 339 348 (C-terminal) of human APP, frameshift mutant
synthetic human APP, 44 63 , N-terminal
synthetic human APP, 681 695 , C-terminal
synthetic human APP, 339 348 frameshift mutant, mid portn
N-terminal 1 100 secreted form of APP
synthetic peptide corresponding to aa 681 695 C terminus of APP
synthetic peptide corresponding to aa 44 63 N terminus of human APP
synthetic peptide corresponding to aa 339 348 frameshift mutant APP
44 63 on the N-terminus of APP
synthetic human APP, 681 695 , C-terminal
synthetic 20-aa peptide near the extracellular, N-terminus 44 63 aa) of human APP695
N-terminal epitope ( 60 100 ) on the pre-A4 molecule.
synthetic Alz 90 ( 511 608 Alzheimer precursor protein A4)
carboxyl fragment APP 643 695 /Jonas
synthetic peptide, C-terminal region ( 751 770 ) of APP, conjugated to maleimide-activated KLH.
synthetic peptide, 681 695 human APP
synthetic peptide, 339 348 on mid portion of APP Frameshift Mutant
synthetic peptide, 643 653 at the C-terminus of APLP1, coupled to KLH
synthetic peptide, 643 653 at the C-terminus of APLP1, coupled to KLH
N-terminal region ( 44 63 ) of APP
C-terminal region ( 681 695 ) of APP
Frameshift Mutant( 339 348 )
peptide to the N-terminal region ( 44 63 ) of APP
APP ( 99 126 )
APP ( 99 126 )
KPI domain
synthetic peptide ( 339 348 ) of APP Frameshift Mutant, C-terminal region
carboxyl fragment of APP 643 695 /
Jonas
synthetic 511 608 APP pre A4-695
44 63 on the N-terminus of APP
synthetic peptide of 44 63 on the N-terminus of APP
synthetic peptide of 681 695 on the C-terminal of APP
synthetic peptide of 339 348 the C-terminal APP frameshift mutant
44 63
339 348
synthetic peptide, 1 16 A beta
(DAEFRHDS-
GYEVHHQK)
synthetic peptide, 653 662 APP A4, or 1 to 10 of the 4K Aβ peptide generated by β- and γ-secretases
synthetic peptide, 737 751 APP A4, or 85-99 of the C99 fragment generated by β-secretase
synthetic peptide, C-terminal region ( 751 770 ) of APP, conjugated to maleimide-activated KLH.
synthetic peptide, 681 695 human APP
synthetic peptide, 339 348 on mid portion of APP Frameshift Mutant
peptide corr. to 653 652 human APP or 1-10 of the 4 kDa Aβ peptide. Peptide sequence identical in rabbit, pig, bovine, guinea pig and chicken
peptide corr. to 737 751 human APP or 85-99 of the C99 fragment generated by β-secretase cleavage. Peptide sequence identical in monkey, mouse, rat and chicken
synthetic peptide, 653 662 APP A4, or 1 to 10 of the 4K Aβ peptide generated by β- and γ-secretases
synthetic peptide, 737 751 APP A4, or 85-99 of the C99 fragment generated by β-secretase
synthetic peptide, 653 662 APP A4, or 1 to 10 of the 4K Aβ peptide generated by β- and γ-secretases
synthetic peptide, 737 751 APP A4, or 85-99 of the C99 fragment generated by β-secretase
synthetic peptide of 511 608 from APP A4(695)
carboxy fragment APP 643 695 /Jonas
44 63 on the N-terminus of APP
synthetic, 339 348 on the mid-portion of human APP Frameshift Mutant
synthetic peptide, 737 751 human APP
synthetic peptide, 653 662 human APP
purified synthetic peptide, 681 695 at C terminus of human APP
purified synthetic peptide, 339 348 at C terminus of APP frameshift mutant
synthetic peptide corr. to 676 695 on C-terminal of APP695
Kunitz Protease Inhibitor domain ( 301 315 ) of APP770
synthetic, 46 60 the N terminus of APP695
amino acid residue 17 24 beta Amyloid peptide
amino acid residue 17 24 beta Amyloid peptide
amino acid residue 17 24 beta Amyloid peptide
amino acid residue 1 17 beta Amyloid peptide
amino acid residue 1 17 beta Amyloid peptide
amino acid residue 1 17 beta Amyloid peptide
synthetic peptide, 18 38 , of Human APP695
Human APP synthetic peptide ( 653 662 ), identical to human amyloid β peptide (aa. 1-10)
synthetic peptide, C terminal ( 737 751 ) of human APP, same as human C99 fragment (aa. 85-99)
peptide corr. to 348 464 human APP-BP1
N-terminus of Amyloidβ, 595 611 APP
444 592 human APP
444 592 APP
19 35 mouse Bad,
coupled to KLH
1 204 GST-mouse BAD
1 204 GST-mouse BAD
106 119
synthetic mouse Bad.
coupled to KLH
synthetic phospho-
14 3 -3 binding motif
containing peptide
131 141 mouse Bad, synthetic
KLH coupled synthetic peptide corr. to 1 21 human Bad
1 168 , full length
himan Bad
1 168 , full length
himan Bad
synthetic peptide corr. to 1 21 human Bad
107 117 mouse Bad, synthetic
19 35 mouse
Bad, coupled to KLH
39 198 aa of
mouse Bad
39 198 aa of
mouse Bad
39 198 aa of
mouse Bad
39 198 aa of
mouse Bad
131 141
of murine Bad
[RSRHS(pS)
YPAGT]
107 117
of murine Bad
(SPFRGRS
R[pS]APPN), 128 140
of murine Bad
(METRSRH
[pS]SYPAG), 05 117
of murine Bad
synthetic peptide, corr. to 43 61 human Bax
synthetic peptide, corr. to 3 16 human Bax
synthetic peptide, corresponding to 3 16 mouse Bax, not shared by rat or human
synthetic peptide, corr. to 3 16 rat Bax, not shared by mouse or human
synthetic peptide, conj. to KLH, corr. to 12 24 human Bax
( 3 16 )
150 165
106 119 mouse Bad
Synthetic peptide
( 150 165 )
synthetic peptide corresponding to 12 24 human Bax protein; sequence is shared by rat and mouse
KLH conj. synthetic peptide corresponding to 1 21 human Bax protein
synthetic peptide 150 165 ) of human bax protein, coupled to thyroglobulin
synthetic peptide 150 165 ) of human bax protein, coupled to thyroglobulin
synthetic peptide 150 165 ) of human bax protein, coupled to thyroglobulin
synthetic peptide 150 165 ) of human bax protein, coupled to thyroglobulin
44 62 (ELALDPVP- QDASTKKLSEC), coupled to KLH
synthetic peptide corresponding to 3 16 mouse bax
synthetic peptide corresponding to 8 16 mouse bax
synthetic peptide corresponding to
12 24 human bax
peptide corresponding to 98 117 human bax
150 165 the human bax protein
synthetic peptide corresponds to 43 61 the mouseBax-α
synthetic peptide corresponds to 3 16 human Bax. This aa sequence not shared by mouse or rat Bax
synthetic peptide corresponds to 3 16 human Bax. This aa sequence not shared by mouse or rat Bax
Human Bax synthetic peptide corresponding to 44 62
Synthetic peptide corresponding to
3 16 human bax
Synthetic peptide corresponding to
12 24 human bax
Synthetic peptide corresponding to
3 16 human bax
Synthetic peptide corresponding to
12 24 human bax
synthetic peptide, 3 16 (Cys-GSGEQPRGGG-
PTSS) of human bax
synthetic peptide, 3 16 (Cys-GSGEQPRGGG-
PTSS) of mouse bax
synthetic peptide, 3 16 (Cys-GSGEQPRGGG-
PTSS) of rat bax
synthetic pep., 12 24 (Cys-GPTSSEQIMK-
TGA) of human bax
synthetic peptide 3 16 (Cys-GSGEQPR GGGPTSS) of human bax protein
synthetic peptide 3 16 (Cys-GSGEQLG SGGPTSS) of mouse bax protein, not shared by human or rat
synthetic peptide 3 16 (Cys-GSGEQLG GGGPTSS) of rat bax protein, not shared by human or mouse
Synthetic peptide corresponding to
3 16 human bax
synthetic peptide corresponding to
8 16 mouse bax
Synthetic peptide corresponding to 12 24 human bax
peptide corresponding to 98 117 human bax.
amino acid 150 165 the
human bax protein
337 351 human MAP-1 (which associates with the proapoptotic Bax)
synthetic peptide corresponding to aa
43 61 human Bax
synthetic peptide corresponding to aa
43 61 mouse Bax
N-terminal peptide sequence ( 12 24 )
Synthetic peptide corr. to 3 16 the mouse Bax sequence
Synthetic peptide corr. to 12 24 the human Bax sequence
Synthetic peptide corr. to 3 16 the human Bax sequence
Synthetic peptide corresponding to
12 33 human bax
N terminal peptide seq. ( 12 24 ) common to human, mouse and rat
synthetic peptide corresponding to aa
43 61 mouse bax
1 171 ; all but the carboxy terminal 21
aa of mouse Bax
1 171 ; all but the carboxy terminal 21 aa of mouse Bax
3 16 human Bax protein
8 16 murine Bax protein
synthetic peptide corresponding to aa
43 61 human Bax.
synthetic peptide corresponding to 43 61 human Bax.
N-terminal region of human Bax (Bax α, 11 30 with C-terminally added lysine)
within 12 24 , shared
by Bax from human,
rat and mouse
synthetic peptide corresponding to aa
3 16 human Bax
synthetic peptide corresponding to aa
3 16 mouse Bax
peptide corresponding to 3 16 near the
N-terminus of mouse bax
peptide corresponding to 3 16 near the N-terminus of human bax
peptide corresponding to 12 24 located nearthe N-terminus, common to human, mouse and rat
human Bax synthetic peptide ( 44 62 )
55 178
human Bax-α
3 16 mouse Bax
Trevigen
Cat# 2281MC
12 24 human Bax
3 16 human Bax
synthetic peptide corr. to 3 16 Bax protein
synthetic peptide corresponding to
1 21 human Bax
KLH conj. peptide corresponding to 3 16 near theN-terminus of human Bax
KLH conj. peptide corresponding to 3 16 near theN-terminus of human Bax
KLH conj. peptide corresponding to 3 16 near theN-terminus of human Bax
KLH conj. peptide corresponding to 12 24 near theN-terminus
a synthetic peptide corr. to aa. 485 501 at the c-terminus of BACE1, coupled to KLH
44 59 human BACE
485 501 , (CLRQQHDD FADDISLLK) of human BACE
a synthetic peptide corr. to 496 511 near the C-terminal of human BACE2
a synthetic peptide corr. to 44 59 near the N-terminal of human BACE2
synthetic peptide, 44 59 human BACE2, N terminal
synthetic peptide, 496 511 human BACE2, C terminal
peptide corresponding to 485 501 near the C-terminal of human BACE
synthetic peptide, CLRQQHDD FADDISLLK, 458 501 Human BACE
synthetic peptide, 485 501 Human BACE
synthetic peptide, 441 457 Human BACE2
synthetic peptide, 485 501 human β-secretase 1
synthetic peptide, 496 511 human β-secretase 2
synthetic peptide, 44 59 human β-secretase 2
synthetic peptide, 26 45 human β-secretase 1
synthetic peptide, 46 65 human β-secretase 1
a synthetic peptide corr. to aa. 26 45 human BACE
a synthetic peptide corr. to aa. 46 65 human BACE
a synthetic peptide corr. to aa. 487 501 human BACE
a synthetic peptide corr. to aa. 131 142 human BACE2
a synthetic peptide corr. to aa. 131 142 human BACE2
a synthetic peptide corr. to aa. 485 501 at the c-terminus of BACE1, coupled to KLH
synthetic peptide corr. to 496 511 (C-term) of human BACE2
synthetic peptide corr. to 44 59 (N-term) of human BACE2
synthetic peptide, 485 501 human BACE, C terminal
synthetic peptide, CLRQQHDD FADDISLLK, 458 501 Human BACE
synthetic peptide, CLRQQHDD FADDISLLK, 458 501 Human BACE
synthetic peptide, 485 501 Human BACE
synthetic peptide, corr. to 441 457 human BACE2
synthetic peptide, corr. to 503 518 human BACE2
synthetic peptide, 122 131 Human BACE
synthetic peptide, corr. to 496 511 human BACE2
synthetic peptide, corr. to 44 59 human BACE2
14 aa peptide of human APP 590 603
Acetyl-EISEVKM DA EFR D-amide
14aa peptide of human APP 590 603
Acetyl-EISEVNL DA EFR D-amide
synthetic peptide, 122 131 human β-secretase 1
485 501 BACE
synthetic peptide corr. to 458 501 BACE
synthetic peptide, 503 518 Human BACE2
synthetic peptide, 122 131 Human BACE
synthetic peptide, 496 511 Human BACE2
synthetic peptide, 44 59 Human BACE2
a synthetic peptide corr. to 44 59 near the N-terminal of human BACE2
a synthetic peptide corr. to 496 511 near the C-terminal of human BACE2
485 501 , (CLRQQHDDFADDISLLK) of human BACE
a synthetic peptide corr. to 44 59 near the N-terminal of human BACE2
a synthetic peptide corr. to 496 511 near the C-terminal of human BACE2
a synthetic peptide corr. to 485 501 near the C-terminal of human BACE
purified, NS0-derived recombinant human BACE-1 ectodomain ( 22 460 )
purified, NS0-derived recombinant human BACE-1 ectodomain ( 22 460 )
peptide mapping corr. to 419 501 at the carboxy terminus of mouse BACE
synthetic peptide corresponding to 44 59 , N-terminal of human BACE2
synthetic peptide corresponding to the C-terminal aa 458 501 human BACE
synthetic peptide conjugate to KLH, corr. to 1 10 human CDK5
synthetic peptide conj. to KLH, corr. to 192 209 human p35 Nck5a
recombinant protein corresponding to 69 140 mapping near the amino terminus of human p35
1 291 representing full length human Cdk5
1 291 representing full length Cdk5 of human origin.
peptide based on the human 33 kDa Cdk5 encoded protein kinase ( 268 283 ) coupled to KLH
15-residue synthetic peptide based on human Cdk5-encoded protein kinase ( 268 283 )
15 residue synthetic peptide ( 268 283 ) based on human 33 kDa Cdk5
synthetic peptide conjugate to KLH, corr. to 1 10 human CDK5
synthetic peptide conjugated to KLH, corresponding to 192 209 Human p35 Nck5a
synthetic peptide conjugated to KLH, corresponding to 192 209 Human p35 Nck5a
recombinant protein corresponding to 69 140 mapping near the amino terminus of human p35
1 291 representing full length Cdk5 of human origin
1 291 representing full length Cdk5 of human origin.
15 residue synthetic peptide ( 268 283 ) based on the human 33-kDa Cdk5-encoded protein kinase
306 314
Chromogranin B ( 1 14 )
synthetic GAWK 20 30 ) [Chromogranin B, 420-493], conjugated with BSA
Chromogranin C ( 1 14 )
GAWK [Chromogranin B, 440 513 ]
250 301
264 314
264 314
264 314
264 314
264 314
1 15 human chromogranin A, KLH conjugate
1 14 human chromogranin B, KLH conjugate
1 14 human chromogranin C, KLH conjugate
Synthetic Chromogranin 420 493 , BSA conj
Chromogranin B ( 1 14 )
Chromogranin C ( 1 14 )
GAWK [Chromogranin B, 440 513 ]
synthetic GAWK 20 30 ) [Chromogranin B, 420-493], conjugated with BSA
Chromogranin A [Tyro] 306 314 , rat
purified fragment containing aa 116 439 in chromogranin A
purified fragment containing aa 116 439 in chromogranin A
chromogranin A, 1 15
chromogranin B, 1 14
chromogranin c, 1 14
chromogranin, GAWK 10 20
509 617 the carboxy terminus of human chromogranin A
recombinant protein corresponding to 158 457 mapping at the carboxy terminus of chromogranin A of human origin
recombinant protein corresponding to 378 677 mapping at the carboxy terminus of chromogranin-B of human origin
rat Chromogranin B, 200 389
rat Chromogranin A, 111 220
prokaryotic recomb. protein corr. to 30 163 N-terminus of human COX-2
prokaryotic recomb. protein corr. to 30 163 N-terminus of human COX-2
synthetic peptide corresponding to 272 282 sheep seminal vesicle COX-1
synthetic peptide corr. to C terminal 567 599 mouse/rat COX-2
synthetic peptide corr. to C terminal 570 598 human COX-2
synthetic peptide corr. to 274 288 mouse COX-1
synthetic peptide corr. to 580 590 human COX-2
C-terminal peptide containing 580 598 human Cox-2
recombinant protein corresponding to 63 124 mapping nearthe amino terminus of human Cox-1
recombinant protein corresponding to 50 111 mapping nearthe amino terminus of human Cox-2
sequence 368 604 on C-terminal of rat COX-2 protein
sequence 368 604 on C-terminal of rat COX-2 protein
578 596 human COX-2
synthetic peptide from the C terminus of murine/rat COX-2 570 598
synthetic peptide from the C terminus of COX-2 567 599
synthetic peptide from the ovine seminal vesicle COX-1 272 282
synthetic peptide from the murine COX-1 sequence, conjugated to KLH, 274 288
synthetic peptide, from the human Cox-2 sequence, 580 599
synthetic peptide, from the human Cox-2 sequence, 580 599
synthetic peptide from the murine COX-2 sequence, 584 598
synthetic peptide, from the human Cox-2 sequence, 580 599
synthetic peptide from the murine COX-2 sequence, 584 598
prokaryotic recomb. protein corr. to 30 163 the N-terminus of human COX-2
C-terminal peptide containing 580 598 human Cox-2
recombinant protein corresponding to 63 124 mapping nearthe amino terminus of human Cox-1
recombinant protein corresponding to 50 111 mapping nearthe amino terminus of human Cox-2
Prokaryotic recombinant fusion protein corr. to 38 163 the N-terminal domain of human COX-2
C-terminal peptide containing 580 598 human Cox-2
recombinant protein corresponding to 63 124 mapping nearthe amino terminus of human Cox-1
recombinant protein corresponding to 50 111 mapping nearthe amino terminus of human Cox-2
synthetic peptide from the C terminus of murine/rat COX-2 570 598
synthetic peptide from the C terminus of COX-2 567 599
synthetic peptide from the ovine seminal vesicle COX-1 272 282
synthetic peptide from the murine COX-1 sequence, conjugated to KLH, 274 288
synthetic peptide, from the human Cox-2 sequence, 580 599
synthetic peptide, from the human Cox-2 sequence, 580 599
synthetic peptide from the murine COX-2 sequence, 584 598
synthetic peptide, from the human Cox-2 sequence, 580 599
synthetic peptide from the murine COX-2 sequence, 584 598
peptide corr. to 584 598 rat COX-2. Identical to mouse sequence
Prokaryotic recombinant fusion protein corr. to 38 163 the N-terminal domain of human COX-2
synthetic peptide corresponding to 272 282 sheep seminal vesicle COX-1
synthetic peptide corr. to C terminal 567 599 mouse/rat COX-2
synthetic peptide corr. to C terminal 570 598 human COX-2
synthetic peptide corr. to 274 288 mouse COX-1
synthetic peptide corr. to 580 590 human COX-2
recombinant, full-length Human ERAB protein (GST Fusion protein), 61 67
recombinant full-length human ERAB protein (GST fused); epitope mapped to 61 67 .
recombinant, full-length human ERAB protein (GST fused); epitope is 61 67
human ERAB, 41 57
recombinant, full-length human ERAB protein (GST fused); epitope at 61 67
synthetic peptide corr. to 100 116 human ERAB, N-terminal KLH conj
synthetic peptide corr. to 101 119 mouse ERAB
Recombinant, full-length human ERAB protein (GST fused); cloneÕs epitope maps to 61 67
recombinant, full-length Human ERAB protein (GST Fusion protein), 61 67
synthetic peptide conjugated to KLH (N-terminal cysteine; epitope is 100 116
recombinant, full-length human ERAB protein (GST fused); epitope is 61 67
Recombinant, full-length human ERAB protein (GST fused); cloneÕs epitope maps to 61 67
recombinant, full-length human ERAB protein (GST fused); epitope is 61 67
synthetic peptide conj. to KLH, corresponding to 187 196 human FADD
synthetic peptide conj. to KLH, corresponding to 187 196 human FADD
recombinant protein corr. to 28 209 mapping at the C terminus of human FADD
C-terminal human FADD, 94 208
synthetic peptide [(C)KIDSIED RYPRNLTER] corresponding to 125 140 human FADD
human FADD synthetic peptide, 125 140 , with an additional cysteineresidue coupled to KLH
mouse FADD synthetic peptide, 125 140 , with an additional cysteineresidue coupled to KLH
16 residue synthetic peptide (C)KIDSIEDR YPRNLTER based on the human FADD ( 125 140 ) with the cysteine (C) residue added and the peptide coupled to KLH
recombinant protein corr. to 28 209 mapping at the C terminus of human FADD
GST-FADD fusion protein corr. to full length human FADD, 1 208 ; different epitope from clone 1F7
synthetic peptide conj. to KLH, corresponding to 187 196 human FADD
16-residue synthetic peptide based on 125 140 human FADD
recombinant protein corr. to 28 209 mapping at the C terminus of human FADD
16 residue synthetic peptide (C)KIDSIEDR YPRNLTER based on the human FADD ( 125 140 ) with the cysteine (C) residue added and the peptide coupled to KLH
recombinant protein derived from 94 208 the human FADD
Fusion protein containing 269 320 from human m1 AChR
synthetic peptide conjugated to KLH, corresponding to 32 45 Human CHRNA4
synthetic peptide conjugated to KLH, corresponding to 34 47 Human CHRNB2
synthetic peptide conjugated to KLH, corresponding to 28 42 Human CHRNA7
synthetic peptide, corresponding to 17 24 human beta Amyloid
synthetic peptide, conj. to KLH, corr. to 1 14 human beta Amyloid
synthetic peptide, conj. to KLH, corr. to 1 40 beta Amyloid
synthetic peptide, conj. to KLH, corr. to 1 17 human β-Amyloid (epitope within aa 3-8)
synthetic peptide, conj. to KLH, corr. to 32 40 human β-Amyloid 1-40
synthetic peptide, conj. to KLH, corr. to 33 42 human β-Amyloid 1-42
synthetic peptide, corr. to 1 17 human β-Amyloid
synthetic peptide, corr. to 1 16 β-Amyloid
sequence corr. to 653 662 human amyloid A4 protein precursor (APP). Identical to that of rabbit, pig, bovine, guinea pig and chicken
sequence corr. to 737 751 human amyloid A4 protein precursor (APP) or 85-99 of the 4K Aβ peptide generated by β- and γ-secretases
synthetic peptide conjugated to BSA, corr. to 681 695 human APP
synthetic peptide conjugated to BSA, corr. to 44 63 human APP
synthetic peptide corr. to 339 348 human APP frameshift mutant
synthetic peptide corr. to 292 312 the KPI domain of human APP
synthetic peptide: RSRHSS YPAGT, corr. to 107 117 mouse Bad
synthetic peptide: RSRHS(pS) YPAGT, corr. to 107 117 human Bad
synthetic peptide conjugated to KLH, corr. to 65 74 human Bcl2
synthetic peptide: GAAPAPG IFSSQPG-C, corr. to 41 54 human Bcl2
synthetic peptide, 3 14 (Cys-QSNRE LVVDFLS) of human Bcl-X protein; sequence is shared by human and murine bcl-X
synthetic peptide, conj. to KLH, corr. to 3 14 human and mouse Bcl-xL.
synthetic peptide, 41 54 (GAAPAPG IFSSQPG-Cys), of human bcl-2 protein
recomb. Bcl-2 peptide sequence comprising 51 54 Bcl-2 oncoprotein
synthetic peptide, corr. to 5 19 human Bcl-10
synthetic peptide sequence comprising 51 54 bcl-2 protein
synthetic peptide, 3 14 (Cys-QSNRE LVVDFLS) of human Bcl-X protein
recombinant full length protein, human (epitope resides within 122 168 )
Purified recombinant hBcl-w ( 1 172 , accession number U59747) containing six histidines at the C-terminus
synthetic peptide, corr. to 120 133 human Bcl xS
Synthetic peptide, corr. to 32 45 human beta Catenin, phosphor. at Ser33
synthetic KLH conj. peptide, corr. to 32 45 human beta Catenin (epitope: DSp GIHSp GATTTAPS)
recomb. fragment, corr. to 795 953 Human NFkB reducing kinase NIK
synthetic peptide, corr. to 931 947 Human NFkB reducing kinase NIK
6xHis-tagged fusion protein, corr. to 105 291 Human IkBα
synthetic peptide (DELFPLIF PAEPAQAS), corr. to 2 17 Human NFkB p65
synthetic peptide (TRLVTGAQ RPPDPAP), corr. to 501 515 Human NFkB p65
recomb. fragment, corr. to 433 501 Human NFkB
N-terminal: Epitope mapping corr. to amino acid 4 10 human Aβ-peptide
C-terminal epitope mapping corr. to amino acid 31 40 human Aβ peptide
Aβ 1 42 peptide at the C-terminus
N-terminal: Epitope mapping corr. to amino acid 4 10 human Aβ-peptide
C-terminal epitope mapping corr. to amino acid 31 40 human Aβ peptide
Aβ 1 42 peptide at the C-terminus
recombinant protein corresponding to 100 278 mapping at the carboxy terminus of rat FAS-L
recombinant protein corr. to 1 335 representing full length human FAS
18-aa synthetic peptide sequience from rat FASL, extracellular domain ( 136 146 )
synthetic peptide: ESLKLRRR VHETDKNC conjugated to KLH, corresponding to 29 44 mouse Fas
fusion protein corr. to 21 165 human Fas
recomb. fragment, corr. to C terminal 103 281 human fas ligand
purified recombinant mouse Fas ligand ( 132 279 )
synthetic peptide conjugated to KLH, corr. to 132 145 human fas ligand
Synthetic peptide: (RGQSCNNQ PLNHKVYMR NSKYPEDL), corr. to 196 220 mouse fas ligand
Synthetic peptide: (RGQSCNNQ PLNHKVYMR NSKYPEDL), corr. to 196 220 mouse fas ligand
Synthetic peptide: (RGQSCNNQ PLNHKVYMR NSKYPEDL), corr. to 196 220 mouse fas ligand
Synthetic peptide corr. to 103 281 human fas ligand
synthetic peptide representing 321 335 human fas receptor coupled to thyroglobulin
peptide cor. to 196 220 mouse Fas Ligand protein
peptide cor. to 196 220 mouse Fas Ligand protein.
peptide corr. to 196 220 mouse FasL
peptide corr. to 196 220 mouse FasL, extracellular
immunogen within coding region of the human FasL gene and hasa length of approx. 620 bp located within the region between 30 650 .
coding region of the human Fas gene and
has a length of approx. 500 bp located within the regionbetween 500 1000 .
synthetic peptide corresponding to 196 220 mouse FasL
synthetic peptide corresponding to 196 220 mouse FasL
recombinant human soluble FasL, ( 103 281 )
recombinant human soluble FasL, ( 103 281 )
synthetic peptide corr. to 321 335 human fas receptor, coupled to thyroglobulin
synthetic peptide corresponding to 29 44 mouse Fas (ESLKLRRR VHETDKNC) coupled to KLH
peptide corr. to 261 277 (VSELSLVNF EESQTFFG) of Fas Ligand
synthetic peptide (DSENSNFR NEIQSLV) corr. to 321 335 human Fas protein
synthetic peptide (QLSLINFE ESKTFFGL) corr. to 261 277 mouse Fas ligand
synthetic peptide (MQQPFNYPYP QIYWVDSSAS) corr. to 1 20 human Fas ligand
synthetic peptide (KLRRRVH ETDKNC) corr. to 1 20 mouse Fas protein
peptide sequence ( 130 146 ) from rat FASL
human Fas (epitope at 1 163 )
human Fas (epitope at 1 163 )
peptide cor. to 196 220 mouse Fas Ligand protein
peptide cor. to 196 220 mouse Fas Ligand protein.
peptide corr. to 196 220 mouse FasL
peptide corr. to 196 220 mouse FasL, extracellular
epitope on intracellular domain 305 319 ) and extracellular domain (110-120)
peptide corresponding to mouse FasL 133 147
peptide cor. to 196 220 mouse Fas Ligand protein
peptide cor. to 196 220 mouse Fas Ligand protein.
peptide corr. to 196 220 mouse FasL
peptide corr. to 196 220 mouse FasL, extracellular
synthetic peptide conjugated to KLH, corr. to 132 145 human fas ligand
synthetic peptide conjugated to KLH, corresponding to 317 331 Human CD95
purified recombinant mouse Fas ligand ( 132 279 )
synthetic peptide: ESLKLRRR VHETDKNC conjugated to KLH, corresponding to 29 44 mouse Fas
fusion protein corr. to 21 165 human Fas
recomb. fragment, corr. to C terminal 103 281 human fas ligand
Synthetic peptide: (RGQSCNNQ PLNHKVYMR NSKYPEDL), corr. to 196 220 mouse fas ligand
Synthetic peptide: (RGQSCNNQ PLNHKVYMR NSKYPEDL), corr. to 196 220 mouse fas ligand
Synthetic peptide: (RGQSCNNQ PLNHKVYMR NSKYPEDL), corr. to 196 220 mouse fas ligand
Synthetic peptide corr. to 103 281 human fas ligand
fusion protein corr. to 21 165 human Fas
18.2 kDa protein fragment corr. to 1 163 human Fas
purified CHO-derived rmFas ligand ( 132 279 )
recombinant protein corresponding to 100 278 mapping at the carboxy terminus of rat FAS-L
recombinant protein corr. to 1 335 representing full length human FAS
16 residue synthetic peptide (ESLKLRRR VHETDKNC, 29 44 ) of mouse Fas, coupled to KLH
human Fas (epitope at 1 163 )
116 277 human fas ligand
16 residue synthetic peptide (ESLKLRRR VHETDKNC, 29 44 ) based on mouse Fas and coupled to KLH
synthetic peptide corr. to intracellular domain ( 104 114 ) of human Fas conj. with KLH
synthetic peptide corr. to 22 37 Human FGFR2, conjugated to KLH
synthetic peptide corr. to 39 56 Human FGFR4, conjugated to KLH
1 23 synthetic fragment of rat FGF-2 (1-46)
1 24 synthetic fragment of bovine basic FGF (1-46)
synthetic peptide conjugated to KLH, corr. to 1 24 Cow FGF2
synthetic peptide: EALEERP AVMTSPLK, conj. to KLH, corr. to 360 373 Human FGFR1 with a C-terminal lysine
synthetic peptide: KLPQYPH IGSVKT, conj. to KLH, corr. to 809 821 the cytoplasmic region of Human FGFR2
synthetic peptide: APGREKE ITASPDK, conj. to KLH, corr. to 362 374 Human FGFR2
synthetic peptide: KDLLPPAP PSSGGSRT, conj. to KLH, corr. to 792 806 the cytoplasmic region of Human FGFR3, with N-terminal added lysine
synthetic peptide: AEEELVE ADEAGSVK, conj. to KLH, corr. to 359 372 Human FGFR3
1 24 synthetic fragment of bovine FGF-2
1 23 synthetic fragment of rat FGF-2 (1-46)
recombinant protein corresponding to 1 208 (full length) hFGF-9
recombinant protein corresponding to 16 140 hFGF-1
10 140 hFGF-2
recomb. protein corr. to 1 208 , (full length) hFGF-9
recombinant FGF basic (epitope within 14 40 )
recombinant bFGF (epitope at 14 40 )
peptide corr. to amino 153 166 the mature form of FGF-3
peptide corr. to 147 153 human bFGF
peptide corr. to 40 63 human bFGF
synthetic peptide corresponding to 351 366 hFGFR-1
synthetic bovine FGF 1 24 )
synthetic rat basic FGF 1 23 )
recombinant human FGF basic, within 14 40
recombinant FGF basic, within 14 40
peptide corr. to 147 153 human bFGF
peptide corr. to 40 63 human bFGF
peptide corr. to 351 366 human FGF receptor-1
recombinant FGF basic, within 14 40
recombinant protein corr. to 16 140 representingall but the C-terminal 15 aa. of mature human FGF-1
recombinant protein corr. to 1 208 representingfull length human FGF-9
recombinant protein corr. to 16 140 representing all but the C-terminal 15 aa of mature human FGF-1
recombinant protein corr. to 10 140 representingall but the C-terminal 15 aa of mature human FGF-2
recombinant protein corr. to 22 97 within the intercellular domain of human Flg (FGFR-1)
synthetic peptide corr. to 809 821 C-terminal region of human FGFR-2, with N-terminal added lysine, conj to KLH
synthetic peptides corr. to 55 68 and 150-162 of FGF-9, conj to KLH
synthetic peptides corr. to 1 24 bovine FGF basic
synthetic peptide corr. to 360 373 extra cellular region of human FGFR-1
synthetic peptide corr. to 362 374 extra cellular region of human FGFR-2 (Bek), conj to KLH
E.coli fusion protein containing 23 325 humanFGF receptor β
synthetic peptide corresponding to 119 144 extracellular domain of chicken FGF receptor
recombinant human bFGF, epitope located between aa 14 40
human bFGF, epitope located between aa 14 40
synthetic peptide for C-terminal of human β-Amyloid 1 40
synthetic peptide for C-terminal of human β-Amyloid 1 42
Synthetic peptide: RRRVT-phospho SAARRS conjugated to KLH, corr. to 3 13 Pig GFAP
3 13 GFAP
phospho. peptides corr. to 3 13 GFAP
epitope corresponding to 413 431 mappingat the carboxy terminus of human GFAP
epitope corresponding to 2 19 mapping atthe amino terminus of human GFAP
recomb. protein corresponding to 1 50 mapping at the amino terminus of human GFAP
residues G-E-V-I-K-E-S-K- Q-E-H-K-D-V-M, position: 418 432 GFAP
synthetic peptide RARTSpSFAEPC, corresponding to 16 25 Human GSK3 alpha
synthetic peptide RARTSSFAEPC, corresponding to 16 25 Human GSK3 alpha
synthetic peptide RRTTpSFAE, corresponding to 4 12 Human GSK3 beta
immunogen = synthetic peptide based on the rat GSK-3β isoform-kinase subdomain XI region ( 335 349 )
rat GSK-3β, 1 160
rat GSK-3β, 1 160
synthetic peptide corr. to 1 30 rat Heme Oxygenase-1
immunizing peptide corresponds to aa 1 30 rat HO-1
synthetic peptide corresponds to amino acid 1 30 derived from the N-terminal domain of rat HO-1
recombinant protein corr. to 184 288 at Carboxy term. of human HO-1
recombinant protein corr. to 293 311 at Carboxy term. of human HO-2
synthetic peptide corresponds to 12 25 human HO-1 protein
synthetic peptide corresponds to 246 264 human HO-2 protein
peptide corr. to 246 264 human HO-2
synthetic peptide based on the human HO-1 ( 1 30 ) prepared as a four branched multiple antigen peptide
aa's 1 261 rat HO-1, not the membrane spanning region, but 7 aa's at the N-terminus and 12 aa's at the C-terminus derived from the expression vector, yielding a 280 aa antigen.
aa's 1 261 rat HO-1, not the membrane spanning region, but 7 aa's at the N-terminus and 12 aa's at the C-terminus derived from the expression vector, yielding a 280 aa antigen.
synthetic peptide based on the human HO-2 ( 21 50 ) prepared as a four branched multiple antigen peptide.
synthetic peptide corresponds to 12 25 )+Cys-NH2 of human HO-1 protein.
synthetic peptide corresponds to 246 264 , amidated form, of human HO-2 protein.
synthetic peptide corresponding to 12 25 HO-1
synthetic peptide corresponding to 246 265 , amidated form, of human HO-2 protein.
a synthetic peptide corresponds to aa [ 12 25 ]+Cys-NH2 of the human HO-1 protein. Totally conserved in the aligned region from pig, rat and mouse
synthetic peptide based on the human HO-1 ( 1 30 ) prepared as a four branched multiple antigen peptide
aa's 1 261 rat HO-1, not the membranespanning region, but 7 aa's at the N-terminus and 12 aa's at the C-terminus derived from the expression vector, yielding a 280 aa antigen.
aa's 1 261 rat HO-1, not the membranespanning region, but 7 aa's at the N-terminus and 12 aa's at the C-terminus derived from the expression vector, yielding a 280 aa antigen.
synthetic peptide based on the human HO-2 ( 21 50 ) prepared as a four branched multiple antigen peptide.
synthetic peptide corr. to 2 23 rat HO-1 protein; two mismatches with the reported human and rat sequences.
synthetic peptide corr. to 2 23 rat HO-1 protein; two mismatches with the reported human and rat sequences.
synthetic peptide corr. to 247 258 rat HO-1 protein; one mismatch with human, identical to mouse sequence.
synthetic peptide corr. to 2 23 rat HO-1 protein; two mismatches with the reported human and rat sequences.
synthetic peptide corr. to 2 23 rat HO-1 protein; two mismatches with the reported human and rat sequences.
synthetic peptide corr. to 247 258 rat HO-1 protein; one mismatch with human, identical to mouse sequence.
human HO-1 synthetic peptide 1 30 conjugated to KLH
protein fragment from 150 286 N term region of human HO-1
protein fragment from 5 115 N-terminal region of human HO-2
synthetic peptide derived from N-terminal 1 30 rat HO-1
recombinant protein corr. to 184 288 at Carboxy term. of human HO-1
recombinant protein corr. to 293 311 at C-terminus of human HO-2
peptide corr. to 2 23 rat HO-1; differs from human, rat by 2 aa
peptide corr. to 247 258 rat HO-2; differs from human by 1 aa
30 aa peptide based on human HO-1 1 30 )
30 residue synthetic peptide based on the human HO-1 1 30
30 residue synthetic peptide based on the human HO-2 21 50
a synthetic peptide corresponds to aa [ 12 25 ]+Cys-NH2 of the human HO-1 protein. Totally conserved in the aligned region from pig, rat and mouse
a synthetic peptide corr. to 246 264 in the amidated form of the human HO-2 protein. Two substitutions in the aligned region from rat, four from rabbit
immunizing peptide corresponds to aa 1 30 rat HO-1
synthetic peptide corresponds to amino acid 1 30 derived from the N-terminal domain of rat HO-1
83 90 Htt
immunogen at 1171 1177
immunogen at 1844 2131
immunogen at 2703 2911
immunogen at 1171 1177
immunogen at 1171 1177
immunogen at 1171 1177
immunogen at 1171 1177
immunogen at 977 1276
immunogen at 977 1276
immunogen at 1844 2131
immunogen at 1844 2131
immunogen at 2081 2086
immunogen at 2081 2086
immunogen at 2081 2086
immunogen at 2081 2086
immunogen at 2081 2086
immunogen at 2703 2911
immunogen at 2703 2911
immunogen at 2703 2911
amino terminal 1 18
amino terminal 254 271
(epitope within 181 810 human protein)
epitope corr. to 2845 3144 mapping at the C-terminus of human Huntingtin
Huntingtin fragment from 181 810 as a fusion protein
Huntington fragment from 181 810 as a fusion protein
Huntingtin fragment from 181 810 as a fusion protein
Huntingtin fragment from 2146 2541 as a fusion protein
recombinant protein corresponding to 2703 2911 huntingtin
recombinant protein corresponding to 1844 2131 huntingtin
recombinant protein corresponding to 997 1276 huntingtin
recombinant protein corresponding to 1171 1177 huntingtin
recombinant protein corresponding to 1844 2131 huntingtin
recombinant protein corresponding to 2703 2911 huntingtin
recombinant protein corresponding to 997 1276 huntingtin
recombinant protein corresponding to 1844 2131 huntingtin
recombinant protein corresponding to 2703 2911 huntingtin
Huntingtin fusion protein 549 679 , fused to Glutathione S-tranferase
549 679
recombinant protein corr. to 2703 2911 huntingtin
recombinant protein corr. to 1844 2131 huntingtin
recombinant protein corr. to 997 1276 huntingtin
epitope corr. to 2845 3144 mapping at the C-terminus of human Huntingtin
Huntingtin fragment from 1247 1646 as a fusion protein
Huntingtin fragment from 2146 2541 as a fusion protein
Huntingtin fragment from 181 810 as a fusion protein
Huntingtin fusion protein 549 679 , fused to Glutathione S-tranferase
314 325 [DGHGQD TSGQLP] of the 40 kDa mouse HAP40 protein
peptide corr. to 314 325 the 40 kD mouse HAP40 protein
recombinant carboxyl terminal half of the full length human protein (65-kDa); epitope is 750 780
53 352 mapping at the C-terminus of human Endophilin I
peptide corr. to amino acid 314 325 mouse HAP40 protein
synthetic peptide corr. to 314 325 mouse HAP
peptide corresponding to 314 325 the 40 kD mouse HAP40 protein
314 325 [DGHGQD TSGQLP] of the 40 kDa mouse HAP40
25 26 [YRQVSN KLKKR] of the 40 kDa mouse HAP40
peptide corresponding to 314 325 the 40 kD mouse HAP40 protein
314 325 [DGHGQD TSGQLP] of the 40 kDa mouse HAP40
314 325 [DGHGQD TSGQLP] of 40 kDa mouse HAP40
22 amino acid peptide corresponding to 2 23 mouse CBP crosslinked to conalbumin
synthetic peptide corresponding to 314 325 mouse HAP
rat HAP1-A, 100 289
bovine brain MAP2, (epitope = 997 1332 )
synthetic peptide corr. to 1 28 Human MAP2K1
997 1332 of MAP2
epitope within 997 1332 high MW MAP2 isoforms
1 219 human MAP2B
purified, NS0-derived, recombinant human Neurophysin II precursor ( 20 164 )
purified, NS0-derived, recombinant human Neurophysin II precursor ( 20 164 )
epitope at 46 62 hNGF
epitope at 46 62 hNGF
epitope at 58 68 hNGF
1 20 , n terminal
1 20 , n terminal
localized to 46 62 hNGF
localized to 46 62 hNGF
1 20 mapping at the amino terminus of the mature form of human NGF
1 20 mapping at the amino terminus of mature mouse NGF
a synthetic peptide corresponds to aa [ 12 25 ]+Cys-NH2 of the human HO-1 protein. Totally conserved in the aligned region from pig, rat and mouse
a synthetic peptide corr. to 246 264 in the amidated form of the human HO-2 protein. Two substitutions in the aligned region from rat, four from rabbit
recombinant protein corr. to 184 288 at Carboxy term. of human HO-1
recombinant protein corr. to 293 311 at Carboxy term. of human HO-2
NGFR from A875 melanoma cells ( 1 160 )
extracellular fragment from the rat Trk A receptor ( 1 416 )
extracellular fragment from the mouse p75 receptor ( 43 161 )
extracellular fragment from the mouse p75 receptor ( 43 161 )
extracellular fragment from mouse p75
( 43 161 )
extracellular fragment from rat trkA receptor( 1 416 )
recombinant protein corr. to 29 165 within the extracellular domain
a.a. region 606 619 synthetic human Trk
epitope spans aa seq. 1 160 extracellular domain of NGFR/NTR
synthetic peptide corr. to 485 493 human trkA.
synthetic peptide corr. to 671 679 human trkA
synthetic peptide ( 606 619 ) selected from the C-terminal catalytic domain of human trk
NGFR from A875 melonoma cells (epitope within 1 160 , in the extracellular domain of the molecule)
1 160 extracellular domain of NGFR/NTR
777 790 in the C-terminal domain of Trk
synthetic peptide containing 322 346 rat TrkA
778 790 in the highly conserved region of the Trk receptors
recombinant protein corresponding to aminoacids 29 165 mappping within the extracellular domain of NGFR p75 of human origin.
synthetic peptide corr. to C-terminal of rat NGFR p75 ( 407 425 with N-terminally added lysine)
synthetic peptide corr. to 777 790 human TrkA
TrkA fusion protein, 20 355 human TrkA (epitope in extracellular, N-terminal domain)
gel-purified p53-beta-galactosidase fusion protein containing murine p53 from 14 289 (epitope between aa 213 and 217 on human p53)
human fusion protein (epitope at 46 55 human p53)
beta galactosidase fusion protein corr. to 14 389 human p53
synthetic peptide conjugated to KLH, corresponding to 31 40 human p53
murine p53 protein corr. to 14 289 (epitope at aa 212-217)
synthetic peptide: MEEPQSpDPSVEP, corr. to 1 12 human p53
synthetic peptide: MEEPQSDPSVEP, corr. to 1 12 human p53
recomb. full length human protein (wild type) (epitope at 16 25 )
synthetic peptide: GDPERPEA AGLDQDER, corresponding to 2 17 human p53R2
recomb. full length human protein (epitope at 20 25 )
recomb. full length human protein (epitope at 20 25 )
synthetic peptide, corresponding to 213 217 p53
synthetic peptide, corresponding to 371 380 human p53
synthetic peptide, corresponding to 370 378 human p53
synthetic peptide, corresponding to 370 378 human p53
recombinant fragment, human (epitope at 16 25 )
synthetic peptide, corresponding to 20 25 human p53
synthetic peptide, corresponding to 32 79 human p53
full length protein, corresponding to 88 93 p53
synthetic peptide, MFQRLNK MFVGEVS, corr. to 1 14 human p53DINP1
sequence corr. to the mouse p53 protein surrounding serine 389 (epitope maps within the middle region, 212 217 , of p53)
purified recombinant human p53(epitope within 18 30 human p53)
Murine p53-β-galactosidase fusion protein (epitope maps within the middle region, 212 217 , of p53)
recombinant human wild type p53 protein expressed in E. coli(epitope within the N-terminus, 32 79 , of p53)
SV40-transformed mouse B4 cells (epitope maps near the C-terminus, 370 378 , of p53)
recombinant human wild type p53 protein expressed in E. coli(epitope within the N-terminus, 37 45 , of p53)
recombinant human wild type p53 protein expressed in E. coli(epitope within the N-terminus, 37 45 , of p53)
ecombinant human wild type p53 protein expressed in E. coli(epitope within the N-terminus, 11 25 , of p53)
SV40 transformed cell line BALB/c SVA31 E7 (epitope between amino acid 88 93 p53)
recombinant human wild type p53 protein expressed in E. coli (epitope near N terminus, within 19 26 )
recombinant human wild type p53 protein expressed in E. coli (epitope near N terminus, within 19 26 )
recombinant human wild type p53 protein (epitope maps within the N-terminus, 20 25 )
murine p53-β-galactosidase fusion protein containing 14 289 (epitope maps within the middle region [aa 212-217] of p53)
human p53-β-galactosidase fusion protein (epitope maps within 46 55 p53)
SV40-transformed mouse B4 cells (epitope mapping near the C-terminal end, 370 378 )
SV40-transformed cell line BALB/c SVA31 E7 (epitope mapping between 88 93 mouse wild-type p53)
GST p53 fusion protein containing 1 393 human p53
peptide corr. to 377 387 thehuman p53 sequence with an acetylated lysine at position 382
peptide corr. to 310 322 the mouse p53 sequence with an acetylated lysine at position 317
purified, E.Coli-derived recombinant human p53, 7 393
epitope at 213 217
epitope at 85 109
epitope within 32 79
epitope at 20 25
epitope at 370 378 on the C terminus of mouse p53
epitope in 56 65 , which is located the N-terminus region
recombinant p53 peptide (epitope near the N-terminal, between 32 79 aa in the human sequence)
recombinant p53 peptide (epitope between the evolutionally conserved Box III and IVregions, approximately 161 220 aa in the human sequence)
synthetic peptide based on sequence from C-terminal part of bovine PARP automodification domain ( 509 524 )
synthetic peptide, human (epitope within 43 59 , QRQESKKMP VAGGKANK, of PARP2)
epitope found between 216 375 in the DNA binding domain of PARP from purified calf thymus
Synthetic peptide: LGELLSTHLLSP- WGAEVKVEPVE corresponding to 471 493 in the automodification domain of bovine PARP
Synthetic peptide: SKGPVKEEG- TNKSEKRK corresponding to 509 524 from bovine PARP
Synthetic peptide: SKGPVKEEG- TNKSEKRK corresponding to 509 524 in the automodification domain of bovine PARP
Synthetic peptide: KQLPGVKSEG- KRKGDEVD corresponding to 197 214 human PARP-1
Synthetic peptide: GVDEVAK- KKSKKEK, corresponding to 215 228 human PARP-1
Synthetic peptide corresponding to 509 524 , automodification domain of bovine PARP-1
raised against the recombinant DNA-binding domain ( 1 232 ) of human PARP-1
raised against the recombinant automodification domain ( 337 573 ) of human PARP-1
491 494 (HPGE) of human minor vault p193 protein/VPARP (PARP-4)
593 599 (FSKVEDY) of human minor vault p193 protein/VPARP (PARP-4)
506 510 (VALGK) of human minor vault p193 protein/VPARP (PARP-4)
purified calf thymus PARP-1; epitope for this antibody is found between 216 375 in the DNA-binding domain of PARP-1
synthetic peptide corresponding to 509 524 the bovine PARP protein
synthetic peptide corresponding to 197 214 the human PARP protein: KQLPGVKSE- GKRKGDEVD
synthetic peptide corresponding to 215 228 the human PARP protein: GVDEVAK- KKSKKEK
epitope found between 216 375 in the DNA binding domain of PARP from purified calf thymus
based on the sequence from the C-terminal portion of the bovine PARP automodification domain ( 509 524 )
purified poly (ADP-ribose) polymer, chain length of 10 50 units
purified calf thymus PARP (epitope between 216 375 in the DNA binding domain)
synthetic peptide based on sequence from C-terminal part of the bovine PARP automodification domain ( 509 524 )
synthetic peptide corresponding to 509 524 the bovine PARP protein
synthetic peptide corr. to 197 214 the human PARP protein: KQLPGVKSE- GKRKGDEVD
synthetic peptide corr. to 215 228 the human PARP protein: GVDEVAK- KKSKKEK
22 219 human PARP
purified recombinant peptide corr. to 71 329 murine PARP
purified recombinant peptide corr. to 71 329 murine PARP
purified recombinant peptide corr. to 71 329 murine PARP
1 20 mapping at the amino terminus of mouse PARP
synthetic peptide corr. to aa. 509 524 in the automodification domain of Bovine PARP
1 20 mapping at the amino terminus of mouse PARP
764 1014 mapping at the carboxy terminus of human PARP
recombinant protein corr. to a 764 1014 at the C terminus of human PARP
epitope is found between 216 375 in the DNA-binding domain of calf thymus PARP
synthetic PARP N-terminal peptide corr. to aa. 2 20 human PARP, with C-term. added lysine
15 residue synthetic peptide GVDEVAK- KKSKKEKD based on the human PARP ( 215 229 )
18 residue synthetic peptide KQLPGVKSE- GKRKGDEVD based on the human PARP ( 197 214 )
synthetic peptide: AESAESGG PPGAQDSAA, corr. to 2 18 mouse ubiquilin
synthetic peptide: INAKADVLFI APREPGAVSY corr. to C-terminal 688 708 from human nicastrin
synthetic peptide corr. to 688 708 human nicastrin; one aa substitution between human and mouse sequence
synthetic peptide corresponds to 2 18 mouse ubiquilin
synthetic peptide corr. to aa 689 709 at C-terminus of nicastrin
synthetic peptide corr. to aa 62 93 at N-terminus of nicastrin
synthetic peptide corresponds to 690 708 mouse nicastrin
synthetic peptide corr to C-terminus, 693 709 human nicastrin, conj. to KLH
N-terminus 4 15 human PEN-2
synthetic peptide corr. to N-terminus 14 33 human presenilin-1
synthetic peptide corr. to 31 47 human presenilin-2
synthetic peptide corr. to 31 47 human presenilin 2
14 33 aa of N-Terminus, extracellular region
synthetic peptide, 14 33 aa of N-Terminus
synthetic peptide, 31 47 aa of N-Terminus
synthetic peptide corr. to 14 33 N-Terminus
14 33 aa of N-Terminus of presenilin 1
14 33 aa of N-Terminus of S182 protein (exposed to the extracellular region)
Synthetic peptide of 31 47 the N-terminus of human PS-2
275 367 human PS1 fused to C-terminus of maltose binding protein
14 23 Human PS1 conjugated to KLH.
N-terminal of human PS-1 21 80 fused to GST
263 378 Presenilin-1, loop fusion protein
14 33 N-terminus of Presenilin-1
Synthetic peptide 14 33 the N-terminal presenilin-1
Synthetic peptide 31 47 the N-terminal presenilin-2
synthetic peptide corr. to 324 335 from the C-terminus of human PS2
31 46 N-terminus of mouse PS1
synthetic peptide 303 316 the loop region of mouse PS1
7 24 from the N-terminus of the human PS2
purified E.Coli-derived recombinant human PS-1 NTF ( 1 80 )
purified E.Coli-derived recombinant human PS-2 NTF ( 1 80 )
purified E.Coli-derived recombinant human PS-1 CTF ( 298 407 )
purified E.Coli-derived recombinant human PS-2 CTF ( 322 388 )
purified E.Coli-derived recombinant human PS-1 NTF ( 1 80 )
purified E.Coli-derived recombinant human PS-1 CTF ( 298 407 )
purified E.Coli-derived recombinant human PS-2 CTF ( 322 388 )
purified E.Coli-derived recomb. human PS-1 NTF ( 1 80 )
14 33 the N terminus of the human PS-1
31 47 the N-terminus of human PS-2
N-terminus peptide ( 14 33 ) of presenilin-1
synthetic peptide corr. to 31 47 Presenilin-2
synthetic peptide corr. to 31 47 Presenilin-2
79 amino acid 1 79 ) from the N-terminus of the human PS1
79 amino acid 1 79 ) from the N-terminus of the human PS1
epitope at PS1, 1 20
loop domain ( 263 407 ) of PS-1
N-terminus ( 2 81 ) of PS-1
loop domain ( 297 356 ) of PS-2
fusion protein, C-terminal ( 263 407 )
fusion protein, C-terminal ( 297 356 )
454 467 PS1 with glutamate residue added to N terminus to enhance solubility
a GST-PS2loop 301 361 ) fusion Protein
454 467 PS1 with glutamate residue added to N terminus to enhance solubility
320 375 human PS1
amino acid peptide corresponding to 301 313 human synaptophysin
synthetic synaptophysin ( 254 279 ) sequence
synthetic synaptophysin sequence ( 254 279 ), PPD conj.
synthetic peptide corr. to human 301 313 , coupled to KLH
a recombinant protein corresponding to aminoacids 221 313 mapping at the carboxy terminus of synaptophysin of humanorigin
synthetic peptide corr. to human 301 313 , coupled to KLH
rat synaptophysin (epitope between 205 307 )
synthetic peptide corr. to 84 104 rat proNGF
83 120 human tau
159 163
194 198
human recomb. tau (epitope between 19 46 )
synthetic peptide: MAEPRQEF EVMEDHAG, corr. to 1 16 human Tau
23 179 human Tau
epitope = 1 150 at the amino terminus of human Tau-1
( 95 108 sequence of tau in a conformation partially dependent on serine in position 101)
bovine tau, (epitope within 141 178 the rat sequence)
bovine tau (epitope at 83 120 human Tau)
bovine tau (epitope near C-terminal region, 404 441 aa., of the rat sequence)
(epitope = 395 432 )
synthetic peptide, FSSTEKNC, (corr. to 286 293 390) of full-length TGF-β, including signal peptide; corr. to aa 8-15, of 112, of the mature growth factor
GST fusion avian protein, containing chick TGFβR, ( 77 148 )
protein corr. to 1 567 representingfull length human TGFβ-RII
protein corr. to 1 567 representingfull length human TGFβ-RII
protein corr. to 1 567 representingfull length human TGFβ-RII
protein corr. to 1 567 representingfull length human TGFβ-RII
mapping at the carboxy terminus of human TGFβ3,( 301 412 )
mapping within extra cellular domain of human TGFβ-RI ( 26 125 )
protein containing chick TGF-β type II receptor 27 85
protein containing chick TGF-β type II receptor 77 148
GST fusion protein containing chick TGF-β type II receptor 27 85
GST fusion protein containing chick TGF-β type II receptor 77 148
E. coli-expressed mature porcine TGF-β1, ( 280 391 )
E. coli-expressed porcine TGF-β1 ( 280 391 )
GST fusion protein containing chick TGF-β type II receptor ( 27 85 )
GST fusion protein containing chick TGF-β type II receptor ( 77 148 )
GST fusion protein, corr. to 27 85 TGFβ R-II
GST fusion protein, corresponding to 77 148 TGFβ R-II
GST fusion protein, corresponding to 27 85 TGFβ R-II
GST fusion protein, corresponding to 77 148 TGFβ R-II
recomb. protein encoding 26 176 human CD105
GST fusion protein containing chick TGF-βType II receptor ( 77 148 )
GST fusion protein containing chick TGF-βType II receptor ( 27 85 )
protein corr. to 1 567 , full length human TGFβ-RII
protein corr. to 1 567 , full length human TGFβ-RII
protein corr. to 1 567 representingfull length human TGFβ-RII
protein corr. to 1 567 human TGFβ-RII
mapping at the carboxy terminus of human TGFβ3,( 301 412 )
mapping within extra cellular domain of human TGFβ-RI ( 26 125 )
synthetic peptide corr. to C-terminus residues ( 247 266 ) of human ARTS protein, conj. to KLH.
synthetic peptide corr. to 561 579 mouse TGF-β activating kinase (TAK1), conj. to KLH.
ovalbumin conj. synthetic peptide corr. to 287 302 human NAG1/PTGF-β
GST fusion protein of the rat betaglycan extracellular ectodomain ( 31 782 ) expressed in E. coli
extracellular fragment generated from sequences from the third exon of mouse p75 ( 43 161 ).
recombinant protein corresponding to 149 448 mapping at the carboxy terminus of human α-Tubulin
recomb. protein corr. to 210 444 mapping at the C-terminus of human β-Tubulin
recombinant protein corresponding to 269 451 mapping at the C-terminus of human γ-Tubulin
recombinant protein corresponding to 154 450 mappingat the carboxy terminus of δ-Tubulin of human origin
recombinant protein corresponding to 196 475 mappingat the carboxy terminus of ε-Tubulin of human origin
epitope located between 426 450 ; aa 426-430
epitope localizes between 416 430 .
alpha tubulin, N-terminal domain (epitope within 65 97 alpha tubulin)
synthetic peptide conj. to KLH, corr. to 352 366 human ε-Tubulin
purified sea urchin --Lytechinus pictus-- sperm axonemal proteins (epitope localized in the C-terminal region of alpha and beta tubulins, the glutamylated motif at 445 457 alpha tubulin)
synthetic peptide conjugated to KLH, corr. to the N-terminal 38 53 γ-Tubulin
synthetic peptide conjugated to KLH (epitope: EEFATEGT DRKDVFFY-K, 38 53 )
synthetic peptide conjugated to KLH (epitope: EEFATEGT DRKDVFFY, 38 53 )
synthetic peptide conjugated to KLH (epitope: EEFATEGT DRKDVFFY, 38 53 )
synthetic peptide: DEYHAATRPD YISWGTQEQ-K, with N-terminally added Lysine, conjugated to KLH, corr. to 433 451 γ-Tubulin
synthetic peptide: AATRPDYI SWGTQEQ-CG, with N-terminally added cysteine-glycine, conj. to KLH, corr. to 437 451 Xenopus laevis γ-Tubulin
crude tubulin preparation ( 65 79 alpha tubulin)
sea urchin (Lytechinus pictus) sperm axonemal proteins ( 427 432 in sea urchin β-2 tubulin)
purified rat brain tubulin (epitope in the C-terminal part of β-tubulin, between 281 446 )
purified rat brain tubulin (epitope in the C-terminal part of β-tubulin, between 281 446 )
crude tubulin preparation (epitope at 65 79 alpha tubulin)
full length S. cerevisiae native protein, purified (epitope between 414 422 )
fraction of tubulin purified from pig brain by two cycles of polymerization- depolymerization (epitope at 65 97 on N-terminal structural domain)
synthetic peptide: ESESQGPK conjugated to malemide activated KLH ( 441 448 human tubulin)
1 451 representing full length α tubulin of porcine origin
210 444 β tubulin of human origin
149 448 α tubulin of human origin
269 451 at the C-terminus of γ tubulin of human origin
269 451 at the C-terminus of γ tubulin of human origin
purified rat brain tubulin (epitope in the carboxy-terminal part of β-tubulin between 281 446 )
synthetic peptide corr. to the N-terminal region of human γ-tubulin ( 38 53 , with C-terminally added lysine) conjugated to KLH
purified rat brain tubulin (epitope in the carboxy-terminal part of β-tubulin between 281 446 )
sea urchin sperm axonemal proteins (epitope in the C-terminal region of β-tubulin, 427 432 in sea urchin β2-tubulin)
synthetic peptide corr. to the C-terminus of Drosophila γ-tubulin ( 441 457 with N-terminal added cysteine-glycine)
synthetic peptide (corr. to 352 366 ) in the C-terminal region of human ε-tubulin, conjugated to KLH
synthetic peptide corr. to the C-terminus of C. elegans γ-tubulin ( 428 444 with N-terminal added cysteine)
synthetic peptide corr. to aa 441 450 human β-tubulin III with N-terminal added cysteine, conjugated to KLH
synthetic peptide corr. to the C-terminus of human γ-tubulin ( 433 451 , with N-terminally added lysine) conjugated to KLH
synthetic peptide corr. to the C-terminus of xenopus γ-tubulin ( 437 451 , with N-terminally added cysteine- glycine) conjugated to KLH
synthetic peptide corr. to theN-terminal region of human γ-tubulin ( 38 53 , with C-terminally added lysine)
synthetic peptide corr. to theN-terminal region of human γ-tubulin ( 38 53 , with C-terminally added lysine)
purified chick brain tubulin (epitope at 426 430 )
synthetic γ-tubulin peptide (N-terminal 38 53 ) conjugated to KLH
purified sea urchin sperm axonemal proteins (epitope in C-terminal region of α- and β-tubulins, the glutamylated motif at amino acid 445 457 α-tubulin)
(epitope at 65 79 )
( 2 20 the carboxy terminus of ubiquitin of human origin)
1 46 the amino terminus of ubiquitinof bovine origin
epitope corr. to 1 76 full length bovine ubiquitin
epitope corr. to 1 76 full length human ubiquitin
immnuogen = recombinant protein corr. to 251 410 mapping near C-terminus of human VAChT
synthetic peptide corr. to 511 530 from cloned rat VAChT
synthetic peptide corr. to 511 530 from cloned rat VAChT
synthetic peptide corresponding to 511 530 from cloned rat VAT
synthetic peptide corresponding to 511 530 from cloned rat VAT
synthetic peptide corresponding to 511 530 from cloned rat VAChT
synthetic peptide corresponding to 511 530 from the C-terminal of rat VAChT
synthetic peptide corr. to 511 530 from cloned rat VAChT
synthetic peptide corresponding to 511 530 from cloned rat VAT
synthetic peptide corresponding to 511 530 from cloned rat VAT
synthetic peptide corresponding to 511 530 from cloned rat VAChT
immnuogen = recombinant protein corr. to 251 410 mapping near C-terminus of human VAChT
immnuogen = synthetic peptide corr. to C-terminal of rat VAChT, conj. to KLH ( 512 530 , with N-terminally added lysine)
purified, E.Coli-derived recombinant mouse p53, 28 325
1 300 mapping at the N-terminus of PARP-1 of human origin
GST-human DJ-1 fusion protein corr. to full length 1 187
GST-human DJ-1 fusion protein corr. to full length 1 187
imunogen = recomb. full-length human DJ-1:GST fusion protein ( 1 187 )
synthetic peptide corresponding to 443 450 (ESESQGPK) of human class III beta-tubulin conj. to KLH.
synthetic peptide, corr. to 40 63 human FGF basic
synthetic peptide 10 30 amino acids in length) at the N-term of first 50 amino acids of human FGF4 conjugated to KLH
recombinant protein to 16 140 hFGF-1
Epitope mapping to 10 130 hFGF-10
recombinant protein corresponding to 1 268 (full length) of hFGF-5
recombinant protein corresponding to 107 200 at C-terminus of hFGF-6
32 104 hFGF-7
53 233 representing all but the N-terminal 52 aa of hFGF-8
25 124
hFGFR-3
25 124 hFGFR-3
25 145 mapping within an extracellular domain of hFGFR-4
1 268 representing full length hFGF-5
53 233 representing all but the N-terminal 52 amino acids of hFGF-8
10 130 human FGF-10
1 208 hFGF-9
25 124 hFGFR-3
25 145 mapping within an extracellular domain of hFGFR-4
25 124 hFGFR-3
22 101 hBek
recombinant hFGF-12, 67 243 (purified, E.coli derived)
synthetic peptide corresponding to 792 806 the cytoplasmic region of hFGFR-3 with N-terminal added lysine
synthetic peptide corresponding to 359 372 extracellular region of hFGFR-3 conjugated to KLH
synthetic peptide corr. to internal sequence ( 89 100 ) of human GSK3 alpha
synthetic peptide, corresponding to 1 30 human Heme Oxygenase 1
recombinant fragment 1 261 rat HO-1
synthetic peptide 10 33 aa in length) at the N-terminus of the first 100aa of human GSK3α
synthetic peptide 10 30 aa in length) at the C-terminus of last 50aa of human GSK3α
synthetic peptide 10 30 aa in length) at the C-terminal of last 100aa of human GSK3β
synthetic peptide 10 30 aa in length) at the N-terminus of first 50aa of human GSK3β
synthetic peptide 10 30 amino acid in length) at the N-terminal of first 50 aa of human GFAP conjugated to KLH
synthetic peptide 10 30 aa in length) at the C-terminal of last 50 aa of human GFAP conjugated to KLH
synthetic peptide 10 30 aa in length) in the region of 149~164 of hHIP2
synthetic peptide 10 30 aa in length) at the C-terminal of last 50 aa of hHAP1 conjugated to KJH
synthetic peptide 10 30 aa in length) at the C-terminal of last 100 aa of hHAPIP conjugated to KLH
synthetic peptide corresponding to C-terminal 206 217 human GRB2
1 217 GRB2
synthetic peptide SWDVETATELLLSN, corresponding to C-terminal 187 200 hHIP2
1 217 GRB2
synthetic peptide corresponding to 4 12 human GSK3β
synthetic peptide corresponding to 12 25 and Cys-NH2 of human HO-1
synthetic peptide corresponding to 246 264 amidated form of the human HO-2 protein
huntingtin fragment from 181 810
synthetic phospho-peptide corresponding to 302 314 mouse Akt (PKB)
synthetic peptide corresponding to 672 713 derived from full-length hβ-amyloid precursor protein
synthetic peptide corresponding to 672 713 derived from full-length hβ-amyloid precursor protein
synthetic peptide corresponding to 672 713 derived from full-length hβ-amyloid precursor protein
synthetic peptide corresponding to 672 713 derived from full-length hβ-amyloid precursor protein
synthetic peptide corresponding to 672 713 derived from full-length hβ-amyloid precursor protein
synthetic peptide corresponding to 672 713 derived from full-length hβ-amyloid precursor protein
synthetic peptide corresponding to 672 713 derived from full-length hβ-amyloid precursor protein
synthetic peptide corresponding to 672 713 derived from full-length hβ-amyloid precursor protein
synthetic peptide corresponding to 672 713 derived from full-length hβ-amyloid precursor protein
synthetic peptide corresponding to 672 713 derived from full-length hβ-amyloid precursor protein
synthetic peptide corresponding to 672 713 derived from full-length hβ-amyloid precursor protein
synthetic peptide corresponding to 672 683 derived from full length hβ-amyloid precursor protein
synthetic peptide conjugated to BSA, corresponding to 461 477 human AKT1
synthetic peptide (coupled to KLH) corresponding to 88 100 human AKT1 α -isoform with an added cysteine residue
synthetic peptide corresponding to 302 314 mouse protein kinase B
synthetic peptide corresponding to 106 122 human AKT1
synthetic peptide (coupled to KLH) from 400 500 seq of human AKT1
synthetic peptide from within 100 200 human AKT2 conj to KLH
synthetic peptide corresponding to the C-terminus ( 460 480 ) of human, rat, mouse and chicken AKT proteins conj to KLH
synthetic peptide corresponding to C-terminus 460 480 human, mouse, rat and chicken AKT proteins (conj KLH)
synthetic peptide corresponding to 302 311 human AKT conj to KLH
synthetic peptide corresponding to 455 468 human AKT2 conj KLH
rat AKT 1peptide 465 480 aa) containing a phosphorylated Ser472 conj. KLH
mouse Aktα ( 375 479 ) derived from E. coli
amino acid 2 200 human AKT
106 122 human AKT1
108 124 human AKT2
synthetic peptide 302 314 mouse AKT
rat AKT1 peptide 465 480 containing a phosphorylated Ser472
synthetic peptide corr. to C-terminal 697 703 hAPPL
synthetic peptide corresponding to the C-terminus 460 480 human, mouse, rat and chicken AKT proteins conj. to KLH.
synthetic peptide corresponding to 302 311 human, AKT protein conj. to KLH.
(epitope at 12 25 )
(epitope at 246 264 )
1 50 human GFAp
recombinant protein corresponding to 148 217 mapping at C-terminus of human GRB2
1 68 mapping at the N-terminus of human GRB2
148 217 mapping at the C-terminus of human GRB2
408 483 mapping at the C-terminus of human GSK3α
345 420 mapping at the C-terminus of human GSK3bβ
1 420 representing full length Xenopus GSK3β
1 420 representing full length Xenopus GSK3β
1 420 representing full length Xenopus GSK3β
465 480 peptide of rat AKT1 containing phosphorylated Ser472 conj to KLH
345 480 human AKT1
345 480 human AKT1
345 480 human AKT1
345 480 human AKT1/2
synthetic peptide corresponding to 1 30 human HO-1
recombinant protein corresponding to 239 311 mapping near the C-terminus of human HO-2
epitope corr. to 549 679
peptide corresponding to 314 325 mouse HAP40
372 671 mapping at the C-terminus of human HAP1
cDNA 290 426 rat HAP1
raised against human tau (epitope = first repeat of MBD, 257 274 )
raised against human tau (epitope = second repeat of MBD, 273 283 )
raised against human tau (epitope = C terminal end, 426 441 )
amino acid 71 184 human Akt/PKBα
synthetic phospho-peptide corresponding to 464 479 Akt1 phosphorylated at serine 473
synthetic peptide corresponding to 466 479 mouse Akt1
synthetic peptide, C-terminal ( 313 334 )
synthetic peptide, N-terminal ( 21 34 )
synthetic peptides, ( 311 322 ) and (aa 342-353)
synthetic peptide, ( 31 45 )
synthetic peptide, C terminal ( 317 334 )
amino acid 150 286 human HO-1
amino acids 5 115 at N-terminal of human HO-2
rat HAP1-A 100 289
human HIP1 228 337
mouse Hip1R 560 772
peptide corresponding to the C-terminus of the large subunit of human ( 163 175 ) and mouse (CRGTELDC-GIETD) caspase-3
recomb. protein corresponding to 1844 2131 huntingtin
recomb. protein corresponding to 2703 2911 huntingtin
recomb. protein corresponding to 997 1276 huntingtin
peptide corresponding to the C-terminus 466 480 Akt coupled to KLH
synthetic peptide corresponding to aa residues Cys+ 384 397 human tau isoform 6 (2N4R) protein, conjugated to KLH
synthetic peptide corresponding to aa residues Cys+ 384 397 the human tau isoform 6 (2N4R) protein, conjugated to KLH
synthetic peptide sequence corresponding to aa 12 25 +Cys-NH2 of human HO-1 conjugated to KLH
synthetic peptide sequence corresponding to aa 245 264 , in amidated form, of human HO-2 conj to KLH
synthetic peptide corr. to C-terminus 460 480 human, mouse, rat and chicken AKT proteins conj to KLH.
synthetic peptide corr. to C-terminus 302 311 human AKT protein conj to KLH.
recomb. protein corresponding to 997 1276 huntingtin
recomb. protein corresponding to 2703 2911 huntingtin
recomb. protein corresponding to 997 1276 huntingtin
synthetic peptide corresponding to 40 63 hFGF basic
synthetic peptide corresponding to aa 642 661 human glycogen synthase
synthetic peptide corresponding to rat GSK-3β isoform-kinase subdomain XI region ( 335 349 )
peptide corresponding to 134 145 human Akt1
peptide corresponding to 134 145 human Akt1
synthetic peptide corr. to 108 121 human Akt2
synthetic peptide α-isoform, 88 199 , of human Akt1 with an added cysteine coupled to KLH
peptide corresponding to 2 23 rat HO-1 conj to KLH
synthetic peptide [MANIAVQRIKRE(C)] corresponding to amino acids 1 12 E2-25K/Hip-2
163 175 murine caspase-3
163 175 murine caspase-3
89 100 human GSK-3α
21 36 human GSK-3β
synthetic peptide (18 residues)corresp. to 203 219 derived from a region of the catalytic domain of Drosophila GSK-3/shaggy enzyme, coupled to ovalbumin.
synthetic peptide corresponding to 203 219 derived from a region of the catalytic domain of the Dropophila GSK/shaggy enzyme coupled to ovalbumin
synthetic peptide corresponding to 6 12 human GSK-3β
synthetic peptide corresponding to 16 26 human phospho-GSK3α (Ser21) with an N-terminal cysteine added for conjugation.
synthetic peptide corresponding to 16 26 human phospho-GSK-3α (Ser21) with an N-terminal cysteine added for conjugation.
synthetic peptide corresponding to 335 349 rat GSK-3β conj to KLH
GST-fusion protein corresponding to 1 149 human Akt-1
synthetic polypeptide ( 1 20 ) of rat synaptobrevin 2, conj. with KLH
polypeptide ( 124 134 ) including phosphorylated Ser129 of human alpha-Synuclein
synthetic peptide corresponds to 245 265 from human APH-1a Long/CT
synthetic peptide, 441 457 human β-secretase 2
synthetic peptide, 503 518 human β-secretase 2
peptide corr. to N-terminal amino acid 43 62 from rat DBH protein
peptide corr. to amino acid 157 172 from human ECT protein
peptide corr. to amino acid 780 793 from human furin
immunizing peptide corr. to amino acid 103 114 from human Prx 1
immunizing peptide corr. to amino acid 104 115 from human Prx 2
immunizing peptide corr. to 436 441 from human versican protein; sequence is completely conserved between mouse and rat
huntingtin fragment from 1247 1646 as a fusion protein
recomb. human huntingtin, 115 129 .
recomb. human huntingtin, 1 82
444 amino acid peptide containing N-terminal histidine tag corresponding to 1736 2179 mouse CBP (CREB binding protein)
synthetic peptide corresponding to 672 683 derived from full length hβ-amyloid precursor protein
synthetic peptide corresponding to 672 683 derived from full length hβ-amyloid precursor protein
synthetic peptide corresponding to 672 683 derived from full length hβ-amyloid precursor protein
synthetic peptide corresponding to 672 683 derived from full length hβ-amyloid precursor protein
synthetic peptide corresponding to 672 683 derived from full length hβ-amyloid precursor protein
synthetic peptide corresponding to 672 683 derived from full length hβ-amyloid precursor protein
synthetic peptide corresponding to 672 683 derived from full length hβ-amyloid precursor protein
synthetic peptide corresponding to 672 683 derived from full length hβ-amyloid precursor protein
synthetic peptide corresponding to 162 176 in the nuclear factor binding domain of human CBP
synthetic peptide corresponding to 162 176 in the nuclear factor binding domain of hCBP.
synthetic peptide corresponding to 162 176 in the nuclear factor binding domain of hCBP
synthetic peptide corresponding to a portion of human CREB binding protein (CBP) encoded within exon 33. Sequence conserved in 28 31 residues between human and mouse.
synthetic peptide corresponding to 162 176 in the nuclear factor binding domain of human CBP
recombinant protein corresponding to 671 970 mapping within an internal region of human CBP
recombinant protein corresponding to 671 970 mapping within an internal region of human CBP
fusion protein containing 720 1676 mouse CBP
synthetic peptide corresponding to 162 176 in the nuclear factor binding domain of human CBP
444 amino acid peptide containing N-terminal histidine tag corresponding to 1736 2179 mouse CBP
(epitope between 56 78 ) of the human DJ-1 protein
(epitope between 26 56 ) of the human DJ-1 protein
purified recominant human GRB-2 protein (epitope between 54 62 )
synthetic peptide corresponding to aa 89 106 from human aggrecan protein
synthetic peptide corresponding to 119 136 human Akt3.
465 480 peptide of rat AKT1 containing phosphorylated Ser472 conj to KLH
synthetic peptide corresponding to 4 12 human GSK3β
synthetic peptide corresponding to the C-terminus 460 480 human, mouse, rat, chicken AKT proteins coupled to KLH
synthetic peptide corresponding to the C-terminus 460 480 human, mouse, rat, chicken AKT proteins coupled to KLH
synthetic peptide corresponding to 302 311 human AKT protein coupled to KLH
synthetic peptide corresponding to C-terminus 460 480 human, rat, mouse, chicken AKT proteins coupled to KLH
synthetic peptide corresponding to 455 468 human AKT2 protein coupled to KLH
(epitope within 1844 2131 )
(epitope within 2703 2911 )
(epitope within 1171 1177 )
314 325
synthetic peptide corresponding to 460 480 human Akt conj to KLH
synthetic peptide corresponding to 302 311 Akt
synthetic peptide corresponding to 302 314 mouse PKB
C-terminus 460 480 human, rat and chicken Akt proteins conj to KLH
recombinant fragment corresponding to 2 200 human Akt
synthetic peptide corresponding to 88 100 human Akt α isoform with a C-terminal cysteine added and coupled to KLH
synthetic peptide corresponding to 461 477 human Akt1
synthetic peptide corresponding to 108 124 human Akt2
synthetic peptide corresponding to 119 136 human Akt3
synthetic peptide corresponding to 119 136 human Akt3
synthetic peptide RRTTpSFAE, corresponding to 4 12 Human GSK3 beta
synthetic peptide corresponding to 3 13 porcine GFAP
1 217 GRB2
synthetic peptide corresponding to C-terminal 206 217 human GRB2
synthetic peptide corr. to 1 30 rat Heme Oxygenase-1
synthetic peptide corresponding to 1 30 human HO-1
recombinant fragment 1 261 rat HO-1
recombinant fragment corresponding to 18 218 (N-terminal) of human syndecan
recombinant fragment corresponding to 18 218 (N-terminal) of human syndecan
recombinant fragment corresponding to 18 218 (N-terminal) of human syndecan
recombinant fragment corresponding to 18 218 (N-terminal) of human syndecan
recombinant protein corresponding to 997 1276 huntingtin
recombinant protein corresponding to 1844 2131 huntingtin
recombinant protein corresponding to 2703 2911 huntingtin
1171 1177 (HDA region of huntingtin
1844 2131 corresponding to HDB region of huntingtin
recombinant protein corresponding to 2703 2911 huntingtin
recombinant carboxyl terminal half of the full length human protein (65-kDa); epitope is 750 780
synthetic peptide corresponding to aa 95 112 human HIPPI
synthetic peptide derived from 50 150 human HIPPI
314 325 [DGHGQD TSGQLP] of the 40 kDa mouse HAP40 protein
peptide corr. to 314 325 the 40 kD mouse HAP40 protein
synthetic peptide corresponding to 162 176 in the nuclear factor binding domain of human CBP
synthetic peptide corresponding to 464 477 human Akt1
synthetic peptide corresponding to 119 136 human Akt3
synthetic peptide corresponding to 119 136 human Akt3
synthetic phospho peptide corresponding to 302 311 Human AKT protein conjugated to KLH
synthetic phospho peptide corresponding to 416 424 Human huntingtin protein
synthetic peptide 335 349 rat GSK3β
synthetic peptide corresponding to aa 12 25 human HO-1 protein
recombinant protein corresponding to 997 1276 huntingtin
recombinant protein corresponding to 1844 2131 huntingtin
recombinant protein corresponding to 2703 2911 huntingtin
recomb. protein corresponding to 1 50 mapping at the amino terminus of human GFAP
amino acid 181 810 as a fusion protein
amino acid region 1 14 (VETSDHDNSLSVSI) conj to KLH
synthetic peptide corresponding to C-terminal 468 477 human AKT
synthetic peptide corresponding to 302 311 Akt
40 kDa mouse HAP40 protein ( 314 325 )
Synthetic peptide: RRRVT-phospho SAARRS conjugated to KLH, corr. to 3 13 Pig GFAP
peptide corresponding to 460 480 at C-terminus of human, rat, mouse and chicken Akt proteins, conjugated KLH
recombinant fragment corresponding to 2 200 human Akt
synthetic peptide corresponding to 88 100 human Akt α isoform with a C-terminal cysteine added coupled to KLH
synthetic peptide corresponding to 455 468 human Akt2
synthetic peptide corresponding to 108 124 human Akt2
synthetic peptide corresponding to 119 136 human Akt3
synthetic peptide corresponding to 119 136 human Akt3
synthetic peptide corresponding to 302 314 mouse protein kinase B
synthetic peptide corresponding to 455 468 human Akt2
synthetic peptide corresponding to 116 128 rat Akt3
peptide corresponding to 460 480 at C-terminus of human, rat, mouse and chicken Akt proteins, conjugated KLH
recombinant fragment corresponding to 2 200 human Akt
synthetic peptide corresponding to 88 100 human Akt α isoform with a C-terminal cysteine added and coupled to KLH
synthetic peptide corresponding to C-terminal 468 477 human AKT
synthetic peptide corresponding to 302 311 Akt
synthetic peptide corresponding to 106 122 human AKT1
synthetic peptide (coupled to KLH) corresponding to 88 100 human AKT1 α -isoform with an added cysteine residue
synthetic peptide conjugated to BSA, corresponding to 461 477 human AKT1
synthetic peptide corresponding to 108 124 human Akt2
synthetic peptide corresponding to 119 136 human Akt3
synthetic peptide corresponding to 119 136 human Akt3
synthetic peptide RARTSpSFAEPC, corresponding to 16 25 Human GSK3 alpha
synthetic peptide RARTSSFAEPC, corresponding to 16 25 Human GSK3 alpha
synthetic peptide RRTTpSFAE, corresponding to 4 12 Human GSK3 beta
synthetic peptide corr. to internal sequence ( 89 100 ) of human GSK3 alpha
synthetic peptide corresponding to 14 27 human HO2
synthetic peptide corresponding to 14 27 human HO2
synthetic peptide, corresponding to 1 30 human Heme Oxygenase 1
recombinant fragment 1 261 rat HO-1
synthetic peptide corr. to 1 30 rat Heme Oxygenase-1
recombinant fragment corresponding to 18 218 (N-terminal) of human syndecan
recombinant fragment corresponding to 18 218 (N-terminal) of human syndecan
recombinant protein corresponding to 997 1276 huntingtin
synthetic peptide corresponding to 162 176 in the nuclear factor binding domain of human CBP
synthetic peptide derived from 50 150 human HIPPI
Epitope = 54 62
amino acid 2 200 Akt1
amino acid 106 122 Akt1
amino acid 108 124 Akt2
124 144 Akt3
GSK-3α peptide ( 89 100 )
GSK-3β peptide ( 21 36 )
synthetic peptide corresponding to 162 176 in the nuclear factor binding domain of human CBP
(epitope corr. to 103 114 human Prx-1)
(epitope corr. to 104 115 human Prx-2)
peptide corresponding to 335 349 rat GSK-3β
synthetic peptide corresponding to 88 100 human PKB α isoform with a c-terminal cysteine added and coupled to KLH
recombinant human GFAP 292 432 derived from e. coli
synthetic peptide corresponding to 75 90 human Akt1 and Akt2, and aa 74-89 Akt3
E. coli derived recombinant human v-akt murine thymoma viral oncogene homolog 1 ( 2 480 )
recombinant human Aggrecan ( 20 675 ) NSO-derived
recombinant human Aggrecan ( 20 675 ) NSO-derived
recombinant mouse Syndecan-3 ( 45 384 ) NSO-derived
synthetic peptide corresponding to internal sequence 120 133 human Akt3
synthetic peptide corresponding to the C-terminus 460 480 human, rat, mouse and chicken Akt
synthetic peptide corresponding to the C-terminus 460 480 human, mouse, rat, chicken akt
synthetic peptide (DGATMKpTFCG) corresponding to 302 311 human Akt coupled to KLH
synthetic peptide corresponding to 455 468 human Akt2 conj to KLH
synthetic peptide corresponding to 16 25 human GSK3α
synthetic peptide (RARTSSFAEPC)corresponding to 16 25 human GSK3α
synthetic peptide (RPRTTsFAE) corresponding to 4 12 human GSK3β
synthetic peptide corresponding 416 424 human huntingtin
148 217 human GRB2
54 164 mapping to central domain of mouse GRB2
mapping between 1 68 mouse GRB2
148 217 mapping at the C-terminus of human GRB2
1 68 mapping at the N-terminus of human GRB2
1 420 representing full length Xenopus GSK-3β
408 483 at the C-terminus of human GSK-3α
345 480 human Akt1
345 480 human Akt1/2
239 311 human Heme Oxygenase-2
1911 1962 human aggrecan
4092 4391 mapping at the C-terminus of human Perlecan
1 140 mapping near the N-terminus of human Syndecan-4
1 140 mapping near the N-terminus of mouse Syndecan-2
1 300 mapping near the N-terminus of mouse Syndecan-3
82 256 human Syndecan
372 671 mapping at the C-terminus of human HAP1
329 628 at the C-terminus of mouse HAP1B
cDNA 290 426 rat HAP-1
amino acid 671 970 human CBP
recombinant protein corresponding to 997 1276 Huntingtin
recombinant protein corresponding to 1844 2131 Huntingtin
recombinant protein corresponding to 2703 2911 huntingtin
synthetic peptide corresponding to the C-terminal region of human GSK-3β ( 403 420 ) conj to KLH
synthetic peptide corresponding to the C-terminal region of human, rat and mouse Grb2 ( 200 217 ) conjugated to KLH
synthetic peptide corresponding to the C-terminus of mouse glutamine synthetase ( 357 373 ) coupled to KLH
synthetic peptide corresponding to 464 477 human Akt1
synthetic peptide (ASIRE) based on human PKBβ/AKT2 ( 477 481 ) coupled to KLH
synthetic peptide based on the human PKB, α isoform ( 88 100 ) with a cysteine residue added and coupled to KLH
phos-phorylated peptide corresponding to 3 13 porcine GFAP coupled to KLH
synthetic peptide corresponding to 195 217 human Grb2 coupled to KLH
synthetic peptide corresponding to 195 217 human Grb2 coupled to KLH
synthetic peptide corresponding to 195 217 human Grb2 coupled to KLH
synthetic peptide corresponding to 195 217 human Grb2 coupled to KLH
mapping between 1 68 mouse GRB2
54 164 mapping to central domain of mouse GRB2
148 217 mapping at the C-terminus of human GRB2
1 68 mapping at the N-terminus of human GRB2
148 217 human GRB2
mapping between 1 68 mouse GRB2
phos-phorylated peptide corresponding to 3 13 porcine GFAP coupled to KLH
recomb. protein corresponding to 1 50 mapping at the amino terminus of human GFAP
synthetic peptide corresponding to 16 25 human GSK3α
synthetic peptide corresponding to 16 25 human GSK3α
synthetic peptide (RPRTTsFAE) corresponding to 4 12 human GSK3β
immunogen = synthetic peptide based on the rat GSK-3β isoform-kinase subdomain XI region ( 335 349 )
408 483 at the C-terminus of human GSK-3α
1 420 representing full length Xenopus GSK-3β
345 420 mapping at the C-terminus of human GSK-3β
345 420 mapping at the C-terminus of human GSK-3β
synthetic peptide corresponding to the C-terminus 460 480 human, rat, mouse and chicken Akt
synthetic peptide corresponding to the C-terminus 460 480 human, mouse, rat, chicken akt
synthetic peptide (DGATMKpTFCG) corresponding to 302 311 human Akt coupled to KLH
synthetic peptide corresponding to 455 468 human Akt2 conj to KLH
amino acid 671 970 human CBP
peptide corresponding to the C-terminus 466 480 Akt coupled to KLH
345 480 human Akt1
345 480 human Akt1/2
synthetic peptide based on the human PKB, α isoform ( 88 100 ) with a cysteine residue added and coupled to KLH
synthetic peptied (ASIRE) based on the human PKBβ ( 477 481 ) coupled to KLH
1911 1962 human aggrecan
4092 4391 mapping at the C-terminus of human Perlecan
82 256 human Syndecan
1 140 mapping near the N-terminus of mouse Syndecan-2
1 300 mapping near the N-terminus of mouse Syndecan-3
1 140 mapping near the N-terminus of human Syndecan-4
epitope corr. to 2845 3144 mapping at the C-terminus of human Huntingtin
Huntingtin fusion recomb. protein 549 679
amino acid 671 970 human CBP
amino acid 671 970 human CBP
cDNA 290 426 rat HAP-1
372 671 mapping at the C-terminus of human HAP1
329 628 at the C-terminus of mouse HAP1B
365 480 human HIP1
glial fibrillary acidic protein 51 52 kD)
Glial Fibrillary Acidic Protein 51 52 kD)
synthetic peptide corresponding to 1 217 human Grb2
1 217 human Grb2
fusion protein corresponding to 1 149 human Akt1
synthetic peptide corresponding to C-terminus 460 480 human, rat, mouse and chicken Akt
a 13 residue synthetic peptide FHVETPEEREEWT(C) based on human PKB kinase, α isoform ( 88 100 ) plus cysteine coupled to KLH
E. coli expressed mouse Akt ( 375 479 )
2 200 Akt
recombinant protein corresponding to 140 480 human Akt1
synthetic peptide corresponding to 464 477 human Akt1
fusion protein corresponding to 1 149 human Akt1
15 residue synthetic peptide (C-RPHFPQFSYSASGTA) corresponding to the C-terminal ( 466 480 ) of rat Akt1.
synthetic peptide corresponding to 2 200 Akt1
synthetic peptide corresponding to 106 122 human Akt1
106 122 human Akt1
synthetic peptide (FHVETPEEREEWT-C) corresponding to 88 100 human Akt1/PKBα plus cysteine coupled to KLH
synthetic peptide corresponding to the C-terminal 466 480 ) of rat Akt1/PKBα, plus N-terminal cysteine coupled to KLH
synthetic peptide C-RYDSLGSLELDQRTH corresponding to 455 469 human Akt2, coupled to KLH
synthetic peptide (CRYDSLGSLELD QRTH) corresp. to 455 469 human Akt2/PKB, plus N-terminal cysteine, coupled KLH
synthetic peptide (CRYDSLGSLELDQRTH) corresp. to 455 469 human Akt2/PKBβ, plus an N-terminal cysteine, coupled to KLH.
synthetic peptide corresponding to 455 468 human AKT 2. Amino acid sequence: RYDSLG LLELDQRT.
108 124 human Akt2
synthetic peptide corresponding to 108 124 human Akt2
synthetic peptide corresponding to aa 119 136 human Akt3
synthetic peptide corresponding to aa 116 128 rat Akt3.
124 144 human Akt3
synthetic peptide corresponding to 119 131 (CSPTSQID NIGEE) of human Akt3/PKBγ
synthetic peptide corresponding to aa 119 136 human Akt3
synthetic peptide corresponding to 124 144 human Akt3
recombinant protein corresponding to 140 480 human Akt1
recombinant protein containing 140 480 human Akt1
synthetic peptide corresponding to 203 219 derived from a region of the catalytic domain (between subdomain VII and VIII) of the Drosophila GSK-3/ shaggy enzyme (ovalbumin coupled).
Synthetic peptide corresponding to 471 483 rat GSK3α, coupled to KLH
synthetic peptide corresponding to 89 100 human GSK3α
peptide corresponding to 89 100 human GSK-3α
21 36 human GSK-3β peptide
synthetic peptide corresponding to 16 26 the human GSK-3α coupled to KLH
synthetic peptide corresponding to 471 483 rat GSK3α coupled to KLH
Immunogen - synthetic peptide corresponding to 471 483 rat GSK3α
synthetic peptide corresponding to 16 26 human phospho-GSK3α (Ser21), coupled to KLH
synthetic peptide corresponding to 16 26 human phospho-GSK3α (Ser21), coupled to KLH
synthetic phospho-peptide corresponding to 6 12 with phosphorylated Ser9 of human GSK3β
synthetic peptide corresponding to 203 219 derived from a region of the catalytic domain of the Drosophila GSK/shaggy enzyme coupled to ovalbumin
synthetic peptide corresponding to 203 219 derived from the region of the catalytic domain of Drosophila GSK/shaggy enzyme, coupled to KLH
synthetic peptide corresponding to 471 483 rat GSK-3α, coupled to KLH
GST-fusion protein corresponding to aa 1 149 human Akt1
GST-fusion protein corresponding to aa 1 149 human Akt1
GST-fusion protein corresponding to aa 1 149 human Akt1
synthetic peptide corresponding to the C-terminal 466 480 rat Akt1
synthetic peptide corresponding to 455 469 human Akt2/PKBβ
synthetic peptide corresponding to 119 131 human Akt3/PKBγ
synthetic peptide corresponding to the C-terminal 466 480 rat Akt1
synthetic peptide corresponding to 88 199 human Akt1/PKBα Pleckstrin Homology Domain coupled to KLH
synthetic peptide corresponding to 455 469 human Akt2/PKBβ coupled to KLH
synthetic peptide corresponding to 119 131 human Akt3/PKBγ
Immuogen = synthetic peptide corresponding to 301 312 with phospho-Thr at aa 308 of mouse Akt coupled to KLH
synthetic peptide corresponding to 6 12 (RTT[pS]FAE) of human GSK3β coupled to KLH
Synthetic peptide corresponding to 203 219 the catalytic domain (between subdomain VII & VIII) of Drosophila GSK-3/shaggy enzyme coupled to ovalbumin.
synthetic peptide corresponding to 335 349 rat GSK-3β isoform-kinase subdomain XI region
synthetic peptide corresponding to 21 36 human GSK-3β
recombinant rat HO-1 purified from E. coli containing 1 261 from HO-1, 7aa from N-terminus and 12 aa from C-terminus of expression vector
synthetic peptide based on the human HO-1 ( 1 30 )
synthetic peptide corresponding to 1 30 human heme-oxygenase 1 (HO-1). Prepared as a four branched multiple antigen peptide.
human aggrecan 1 14 : V-E-T-S-D-H-D-N-S-L-S-V-S-I).
human aggrecan 1 14 : V-E-T-S-D-H-D-N-S-L-S-V-S-I) coupled to KLH
recombinant protein corresponding to 1844 2131 huntingtin
recombinant protein corresponding to 2703 2911 huntingtin
recombinant protein corresponding to 997 1276 huntingtin
E1A affinity purified p300 protein. Epitope: 2071 2091
E1A affinity purified p300 protein. Epitope: 2071 2091
GST fusion protein corresponding to 1 233 bovine MsrA. Human homology 219/233
synthetic peptide corresponding to 104 115 human Prx1
synthetic peptide corresponding to 103 114 human Prx2
GST fusion protein corresponding to 1 233 bovine MsrA
synthetic peptide corresponding 416 424 human huntingtin
synthetic peptide corresponding to 104 115 human PrxI
synthetic peptide corresponding to 103 114 human PrxII
synthetic phospho-peptide corresponding to 302 314 mouse Akt (PKB)
synthetic peptide corresponding to 119 136 human Akt3.
Synthetic peptide: C-A-A-Q-V-K-A-P-L-V-L-K-D, corresponding to C terminal 178 189 human PARK7/DJ1
synthetic peptide, corresponding to 6 23 human CREB
synthetic peptide K R R E I L S R R P S Y R K corresp. to 123 136 human CREB.
synthetic phospho-peptide K(123) R R E I L S R R P (pS) Y R K (136) corresp. to aa 123 136 from human CREB
synthetic peptide corresponding to a region near the N-terminus ( 5 45 ) of human CREB
synthetic peptide: C T R F T D E Y Q L F E E L corresp. to N terminal 7 20 rat CaMKII (delta isoform )
N-terminal fusion protein corresponding to 25 130 rat NMDA receptor 2C.
C-terminal fusion protein, corresponding to 1253 1391 rat NMDA receptor 2B
1437 1456 mature mouse NR2B or 1463-1482 of NR2B precursor; signal is amino acid residues 1-26 [K F N G S S N G H V Y E K L S S I E S D V]
fusion protein, corresponding to 780 914 from the intracellular IIIIV loop of Human NR3A + NR3B.
fusion protein, corresponding to 1 564 NMDAR1
synthetic peptide containing amino acid 96 113 human κB-Ras1
130 143 human IkBα protein
synthetic peptide corresponding to 34 48 human IkBα protein
recombinant protein corresponding to amino acid 32 391 human IkBα
recombinant protein corresponding to amino acid 32 391 human IkBα was used as immunogen
synthetic peptide within aa 500 600 human TBK-1
synthetic peptide corresponding to 526 539 human NF-kB (p65)
synthetic peptide corresponding to 538 546 human NFκB p65
273 284 (R-R-P-p-D-R-E-L-p-E-P-M) of human NF-kB p65 (p=Ser)
A synthtic peptide conatining amino acid 10 28 (IEIIEQPRQRGMRFRYKCE) of human c-Rel.
A synthetic peptide corresponding to amino acid 276 291 (DFRYLPDEKDTYGNKA) of human c-Rel
peptide V L L S R K R R R Q H G Q C corresp. to 1755 1767 the N-terminal sequence of the cleaved N intracellular domain (NICD).
synthetic peptide C R D A S N H K R R E P V G Q D corresp. to 1719 1733 human activated Notch2
peptide C N A A E R T P S H S G H L Q corresp. to 2396 2409 Notch 2
peptide C E H P F L T P S P E S P D Q corresp. to 2507 2520 at the C-terminus of Notch 1
synthetic peptide: C Q H S Y S S P V D N T P S H Q corresp. to 2488 2502 Notch1 intra
synthetic peptide (A W H A P G D D L R P E A L C) corresp. to 121 134 human Delta4, coupled to KLH
synthetic peptide K A S R G N D R N R I V L P F S C corresponding to 110 125 Human Jagged1 coupled to KLH
synthetic peptide: A G D R A R A R S R T G G H Q D P G corresp. to 111 128 mouse Jagged 2.
synthetic peptide selected within 400 478 human CAMK2α
synthetic peptide selected within 500 550 human CAMK2β.
synthetic peptide selected from 324 338 human CAMK2 δ-like
synthetic peptide selected within 450 499 human CAMK2δ
synthetic peptide selected from 397 411 human CAMK2γ.
Immnogen = synthetic peptide 10 30 aa in length) at the C-term of last 50 aa of human Notch1.
Immunogen synthetic peptide 10 30 aa in length) at the C-term of last 50 aa of human Notch2.
synthetic peptide 10 30 aa in length) at the C-term of last 50 aa of human Notch3
synthetic peptide 10 30 aa in length) at the C-term of last 50 aa of human Notch4
synthetic peptide 10 30 aa in length) at the C-term of last 50 aa of human Jag1
synthetic peptide: C G E E W S Q D L H S S G R T D L R Y S corresponding to 155 173 mouse Delta-1 coupled to KLH
peptide corresponding to a region near the N-terminus ( 5 45 ) of human CREB coupled to KLH
phospho peptide Q K R R E I L S R R P (pS) Y R K I L N D L S S D A P corresp. to 122 147 human CREB
thyroglobulin-coupled peptide corresponding to 17 35 NR1
peptide V L L S R K R R R Q H G Q C corresp. to 1755 1767 the N-terminal sequence of the cleaved N intracellular domain (NICD).
synthetic peptide corresponding to aa 2488 2502 (C Q H S S Y S S P V D N T P S H Q) of human notch 1
peptide C N A A E R T P S H S G H L Q corresp. to 2396 2409 Notch 2
synthetic peptide corresponding to 6 23 human CREB-1
synthetic peptide corresponding to 6 23 human CREB-1
synthetic peptide corresponding to 167 189 (A-I-V-E-A-L-N-G-K-E-V-A- A-Q-V-K-A-P-L-V-L-K- D) of DJ-1/PARK
phospho-peptide corresponds to amino acid 123 136 from human CREB
synthetic peptide corresponding to aa 123 136 (K R R E I L S R R P S Y R K) of CREB
recombinant protein: NR2B subunit amino acid 934 1457
fusion protein corresponding to 1 564 rat NMDA NR1
synthetic peptide corresponding to 125 135 CREB phosphorylated at Ser133
synthetic thiophos-phated (Thr286) peptide corresp. to 281 294 from the α-subunit of mouse and rat CaM kinase II
peptide corr. to a region near the N-terminus ( 5 45 ) of the human protein conj. to KLH
synthetic peptide corresponding to 100 150 human CREB
synthetic peptide corresponding to aa 2507 2520 (C E H P F L T P S P E S P D Q) of human Notch 1
synthetic peptide selected from 397 411 human CAMK2γ.
imunogen = recomb. full-length human DJ-1:GST fusion protein ( 1 187 )
Immnogen = synthetic peptide 10 30 aa in length) at the C-term of last 50 aa of human Notch1.
Immunogen synthetic peptide 10 30 aa in length) at the C-term of last 50 aa of human Notch2.
synthetic peptide 10 30 aa in length) at the C-term of last 50 aa of human Notch3
synthetic peptide 10 30 aa in length) at the C-term of last 50 aa of human Notch4
synthetic peptide 10 30 aa in length) at the C-term of last 50 aa of human Jag1
synthetic peptide 10 30 aa in length) of last 50 aa at the C-term of human Jag2
synthetic peptide 10 30 aa in length) of last 50 aa at the C-term of human Jag2
peptide V L L S R K R R R Q H G Q C corr. to 1755 1767 the N-terminal sequence of the cleaved N intracellular domain (NICD).
synthetic peptide: C Q H S Y S S P V D N T P S H Q corresp. to 2488 2502 Notch1 intra
synthetic peptide C R D A S N H K R R E P V G Q D corresp. to 1719 1733 human Notch2
peptide V L L S R K R R R Q H G Q C corr. to 1755 1767 the N-terminal sequence of the cleaved N intracellular domain (NICD).
synthetic peptide: C Q H S Y S S P V D N T P S H Q corresp. to 2488 2502 Notch1 intra
synthetic peptide C R D A S N H K R R E P V G Q D corresp. to 1719 1733 human Notch2
phospho peptide Q K R R E I L S R R P(pS) Y R K I L N D L S S D A P corresp. to 122 147 human CREB, conj. to KLH
peptide corresponding to a region near the N-terminus ( 5 45 ) of human CREB coupled to KLH
phospho peptide Q K R R E I L S R R P (pS) Y R K I L N D L S S D A P corresp. to 122 147 human CREB, conj. to KLH
peptide corresponding to a region near the N-terminus ( 5 45 ) of human CREB coupled to KLH
C-terminal fusion protein, corr. to 1253 1391 rat NMDA receptor 2A
C-terminal fusion protein, corr. to 984 1104 NMDA receptor 2B
C-terminal fusion protein, corr. to 1253 1391 rat NMDA receptor 2A
C-terminal fusion protein, corr. to 984 1104 NMDA receptor 2B
268 386 human NMCAε4
27 76 mapping within an extracellular domain of human NMDAε 2
19 318 mapping within an extracellular domain of human NMDAζ 1
268 386 mapping to an internal region of human glutamate NMDAε 4
254 327 mapping within the DNA binding and dimerization domain of human CRED-1 p43
254 327 mapping within the DNA binding and dimerization domain of human CRED-1 p43
1 290 human CREB-2
1 290 human CREB-2
1 290 human CREB-2
254 327 human CREB
254 327 human CREB
254 327 mapping within the DNA binding and dimerization domain of human CREB-1 p43
254 327 mapping within the DNA binding and dimerization domain of human CREB-1 p43
25 255 mapping within an extracellular domain of human Notch 2
2107 2240 mouse Notch 3
1779 2003 mapping at the C-terminus of mouse Notch 4
amino acid 1299 1492 (region EGF repeat 33 through LNG repeat 1) of mouse Notch 1
20 150 mapping within an extracellular domain of human Notch 1
207 272 human Jagged
1110 1223 human Jagged
914 1056 human Jagged 2
459 723 human delta
synthetic peptide corresponding to 877 889 (S H S S G M P L G A T G L) at the C-terminus of rat GluR1
synthetic peptide corresponding to 868 881 (R Q S S G L A V I A S D L P) of the C-terminus of rat GLUR4
recombinant trpE fusion protein containing the putative N-terminal 175 430 GluR2
fusion protein encoding GTS in frame with rat NMDAR1 660 811
C-terminal fusion protein corresp. to 25 130 NMDAR2B
C-terminal fusion protein corresp. to 984 1104 NMDAR2B
mouse NMDAR2A 1093 1214 at C-terminus
892 1051 near C-terminus of rat NMDAR2B
C-terminal fusion protein corresp. to 1253 1391 NMDAR2A
CREB-1 (p43) peptide corresp. to a region near the N-terminus ( 5 45 ) of the human protein conjugated to KLH
C-terminal fusion protein of NMDAR2B aa 984 1104
C-terminal fusion protein of rat NMDAR2A, 1253 1391
synthetic peptide corresponding to 125 135 (R E I L S R R P pS Y R) of human CREB phosphorylated at Ser 133
synthetic peptide corresponding to 123 136 human CREB
synthetic phospho-peptide corresponding to 123 136 human CREB
phosphorylated (Thr286) peptide corresponding to 281 294 (M H R Q E T V D C L K K F N) of the mouse/rat CaM kinase II α subunit
fusion protein containing 1253 1391 NMDAR 2A-subunit
fusion protein containing 984 1104 NMDAR 2B subunit
a 17 kDa fusion protein constructed from the N-terminal region 25 130 the rat NMDAR 2C subunit
synthetic phospho-peptide corresp. to 891 902 rat NMDA receptor subunit NR1
synthetic phospho-peptide corresponding to 891 902 rat NMDA receptor subunit NR1
fusion protein containing 1 564 rat NMDA NR1
synthetic peptide corresponding to 271 285 rat GluR1
synthetic phospho-peptide corresp. to 826 836 mature GluR1 from mouse and rat
synthetic peptide corresp. to 840 850 the mature chain, with a phosphorylated serine at position 845.
GST-fusion protein containing 1299 1492 mouse Notch 1
GST-fusion protein corresponding to aa 2272 2488 rat Notch 1
GST-fusion protein corresponding to aa 381 853 rat Notch 1
synthetic peptide corresponding to 162 176 in the nuclear factor binding domain of human CBP
synthetic peptide corresponding to aa 123 136 (K R R E I L S R R P S Y R K) of CREB
phospho-peptide corresponds to amino acid 123 136 from human CREB
synthetic peptide corresponding to aa 123-(pS 133 136 human CREB
synthetic peptide corresponding to aa 123-(pS 133 136 human CREB
fusion protein of NR3A aa 780 914 from the extracellular III-IV loop
fusion protein of NR3A 780 914 from the extracellular III-IV loop.
fusion protein containing aa 25 130 N-terminal of rat brain subunit 2C
fusion protein containing aa 984 1104 C-terminal of rat brain subunit 2B
fusion protein containing aa 1253 1391 C-terminal of rat brain subunit 2A
fusion protein containing 1253 1391 the C-terminal region of rat brain subunit 2A
fusion protein containing 984 1104 the C-terminal region of rat brain subunit 2B
fusion protein containing 25 130 the N-terminal region of rat brain 2C subunit
fusion protein containing 1 564 the NR1-subunit of rat NMDAR
CREB-1 (p43) peptide corresponding to the N-terminal 5 45 human protein conjugated to KLH
synthetic peptide corresponding to 125 135 human CREB conjugated to KLH
synthetic phospho-peptide corresponding to 123 136 rat CREB coupled to KLH
synthetic peptide (REILSRRP[pS]YR) corresp. to 125 135 human CREB
synthetic phospho-peptide corresp. to 123 136 (KRREILSRRP[pS]YRK) of rat CREB coupled to KLH
synthetic peptide (CSGENQQSGDA AVTEAENQQ) corresp. to 5 24 human CREB
synthetic peptide (CSGAENQQSGD AAVTEAENQQ) corresp. to 5 24 human CREB.
C-terminal fusion protein of 1253 1391 rat NMDAR 2A
C-terminal fusion protein of 1253 1391 rat NMDAR 2A
C-terminal fusion protein of 984 1104 from NMDAR 2B
fusion protein of 1 564 rat NR1
a GST fusion protein of amino acid region 1099 1213 from human NMDAR 2A
GST fusion protein of aa region 1033 1161 from human NMDAR 2B
synthetic peptide from 2396 2409 human Notch 2
GST fusion protein comprising 1299 1492 mouse Notch 1
GST-fusion protein corresponding to 1299 1492 mouse Notch 1
His-tag fusion protein containing the C-terminus nucleotides 5708 6217 murine Notch 4
His-tag fusion protein containing the C-terminus nucleotides 5935 6454 murine Notch 3
GST-fusion protein corresponding to 2272 2488 rat Notch 1
N-terminal GST fusion protein corresponding to 381 853 rat Notch 1
GST fusion protein corresponding to 2272 2488 rat Notch 1
N-terminal GST fusion protein corresponding to 381 853 rat Notch 1
His-tag fusion protein containing the C-terminus 5935 6454 murine Notch 3
His-tag fusion protein containing the C-terminus 5708 6217 murine Notch 4
fusion protein from 1 564 rat NMDA NR1
Drosophila Notch extracellular domain, EGF repeat 5 7
Drosophila Notch protein, extracellular domain, EGF repeats # 12 20 , bacterial fusion protein
GST fusion protein Notch intracellular domain nucleotides 6658 7131
synthetic peptide (CSGAENQQSGD AAVTEAENQQ) corresp. to 5 24 human CREB coupled to KLH
synthetic phospho-peptide corresp. to 123 136 [KRREILSRRP(pS)Y-RK] of rat CREB coupled to KLH.
amino acid 1299 1492 (region EGF repeat 33 through LNG repeat 1) of mouse Notch 1
amino acid 1299 1492 (region EGF repeat 33 through LNG repeat 1) of mouse Notch 1
synthetic peptide (REILSRRP[pS]YR) corresp. to 125 135 human CREB coupled to KLH
synthetic peptide (Q-K-R-R-E-I-L-S--R-R-P-[pS]-R-K-I-L-N-D-L-S-S-D-A-P) 122 147 corresp. to the human CREB pS133 coupled to KLH).
synthetic peptide corresponding to 281 294 rat CaM Kinase II α-subunit
synthetic peptide (KMHRQE[pT]VDCLK) correspond. to 281 291 rat CaM Kinase II α-subunit
synthetic peptide C-T-R-F-T-D-E-Y-Q-L-F-E-E-L based on the rat multi-functional CaM kinase II δ isoform ( 7 20 ) coupled to KLH
rat CaMK II synthetic peptide ( 7 20 )1, conjugated to KLH
synthetic peptide corresp. to 499 513 human CAMK2b
synthetic peptide 281 291 (K-M-H-R-Q-E-[pT]V-D-CL-K) corresp. to rat CaMkinase II, subunit
GST fusion protein corresponding to 934 1457 rat NR2B.
6His-tagged fusion protein corresp. to 1265 1464 mouse NMDA receptor 2A (NR2A)
His tag fusion protein corresp. to 834 938 rat NR1A; the epitope maps to a region (834-864) common to all NR1 isoforms
peptide corresponding to 916 930 (C R R V R R A V V E R E R R V R) of mouse NR3B
peptide corresp.to 259 278 (K R Y A P D G I I G L Q L I N G K N E S) of rat NMDA receptor 1, splice variants 1-4 and aa281-300 on all other splice variants
peptide corresp. to 1098 1113 (S R K T E L E E Y Q K T N R T C) of rat NR3A
6His-tagged fusion protein corresp.to 1265 1464 mouse NMDA receptor 2A (NR2A).
peptide corresp. to 1297 1309 human phospho-NR2B
synthetic peptide (K F K R R R S pS K D T S T) corresp. to 891 902 rat NR1A, thyroglobulin conjugated
synthetic peptide (K F K R R R pS S K D T S T) corresp. to 891 902 rat NR1A coupled to thyroglobulin
peptide (C R D H T R V D W K R P K) corresp. to 276 287 rat glutamate receptor 1 (GluR1), plus cysteine for conjugation purposes.
synthetic peptide (T L P R N S G A G A S) corresp. to 858 868 human GluR1
recombinant fusion protein containing GST and NMDAR1 660 811
fusion protein (amino acid 1 564 ) of NMDA NR1
fusion protein from 1 564 NMDA NR1
Amino acid region 1099 1213 from human NMDA R2A produced as a GST fusion protein
C-terminal fusion protein of the NMDA R2B, 984 1104 , 30kD
synthetic peptide corresp. to 1297 1309 (C K L R R Q H (pS) Y D T F V D) of human phospho-NR2B with an N-terminal cysteine added for KLH conjugation
thyroglobulin-conjugated, synthetic peptide (L I P Q Q (pS) I N E A I K) corresp. to 826 836 GluR1 mature chain, with a phosphorylated serine at position 831
recombinant fusion protein TrpE-GluR2 (putative N-terminal portion, 175 430 ).
synthetic peptide (V A K N P Q N I N P S S S Q N S) corresp.to 827 842 the rat GluR2
synthetic peptide (L V Y G I E (pS) V K I A) corresp. to 873 883 rat GluR2, with a phosphorylated serine at position 880,Thyroglobulin-conjugated.
synthetic peptide corresp. to 864 883 (C Q N F A T Y K E G Y N V Y G I E S V K I) of rat GluR2 (KLH coupled).
synthetic peptide corresponding to 864 883 rat GluR2
GST fusion protein corresponding to 1299 1492 mouse Notch 1
synthetic peptide C Q H S Y S S P V D N T P S H Q corresp. to aa 2488 2502 human Notch 1, intracellular domain
synthetic peptide (V L L S R K R R R Q H G Q-C) 1755 1767 at N-terminal sequence of the cleaved N intracellular domain (NICD).
synthetic peptide, V L L S R K R R R Q H G Q C, corresp. to amino acid 1755 1767 human Notch 1
N-terminal GST fusion protein corresponding to 381 853 rat Notch 1
synthetic peptide (C Q H S Y S S P V D N T P S H Q) corresp. to 2488 2502 the intracellular domain of human Notch 1
synthetic peptide corresp. to aa 2507 2520 human Notch 1, intracellular domain, 35 amino acids from the C-terminus.
synthetic peptide C N A A E R T P S H S G H L Q corresp. to aa 2396 2409 human Notch 2, intracellular domain
synthetic peptide (T H M S E P P H N N M Q V Y A) corresp. to 2457 2471 the human NOTCH homolog 2 protein
synthetic peptide (Q L G P Q P E V T P K R Q V L A) corresp. to 2306 2321 the human NOTCH homolog 3 protein (KLH coupled).
his-tag fusion protein containing the C-terminus 5935 6454 murine Notch 3
his-tag fusion protein containing the C-terminus 5708 6217 murine Notch 4
synthetic peptide (C G P P A L Q E M P I N Q G G E G K K) corresp. to 1984 2002 the human NOTCH homolog 4 (NOTCH4) protein.
synthetic peptide comprised of 1204 1218 [D L E S A Q S L N R M E Y I V] of the human jagged 1 (JAG1) protein coupled to KLH
synthetic peptide comprised of 1224 1238 [R A V R S I N E A R Y A G K E] of the human jagged 2 (JAG2) protein coupled to KLH
synthetic phospho-peptide K(123)R R E I L S R R P S (pS) Y R K (136) corresp. to aa 123 136 from human CREB
synthetic peptide, corresponding to 6 23 human CREB
synthetic peptide K R R E I L S R R P S Y R K corresp. to 123 136 human CREB.
synthetic peptide corresponding to a region near the N-terminus ( 5 45 ) of human CREB
synthetic peptide corr. to 281 294 rat CaM kinase II with the phospho. threonine at position 286
synthetic phospho peptide (V R R G S G T P E A E A P R Q) corr. to 499 513 human CaMKII beta
synthetic peptide: C T R F T D E Y Q L F E E L corresp. to N terminal 7 20 rat CaMKII (delta isoform )
synthetic peptide corr. to 281 294 rat CaM kinase II with the phospho. threonine at position 286
fusion protein, corresponding to 1 564 NMDAR1
C-terminal fusion protein, corresponding to 1253 1391 rat NMDA receptor 2B
N-terminal fusion protein corresponding to 25 130 rat NMDA receptor 2C.
fusion protein, corresponding to 780 914 from the intracellular IIIIV loop of Human NR3A + NR3B.
1437 1456 mature mouse NR2B or 1463-1482 of NR2B precursor; signal is amino acid residues 1-26 [K F N G S S N G H V Y E K L S S I E S D V]
fusion protein from 1 564 NMDA NR1
C- terminal fusion protein representing 1253 1391 rat NMDAR2A
C- terminal fusion protein representing 1253 1391 rat NMDAR2B
N-terminal fusion protein (17 kDa) representing 25 130 rat NMDAR2C
fusion protein, corresponding to 1 564 NMDAR1
fusion protein, corresp. to 780 914 from the intracellular IIIIV loop of Human NR3A + NR3B.
synthetic peptide corr. to 281 294 rat CaM kinase II with the phospho. threonine at position 286
synthetic peptide: C T R F T D E Y Q L F E E L corresp. to N terminal 7 20 rat CaMKII (delta isoform )
synthetic phospho peptide (VRRGSGTP EAEAPRQ) corr. to 499 513 human CaMKII beta
synthetic phospho-peptide K(123)R R E I L S R R P (pS) Y R K (136) corresp. to aa 123 136 from human CREB
synthetic peptide corresponding to a region near the N-terminus ( 5 45 ) of human CREB
synthetic peptide K R R E I L S R R P S Y R K corresp. to 123 136 human CREB.
synthetic peptide, corresponding to 6 23 human CREB
synthetic phospho-peptide K(123) R R E I L S R R P (pS) Y R K (136) corresp. to aa 123 136 from human CREB
synthetic phospho-peptide derived from 74 128 human CREB
synthetic phospho-peptide derived from 74 128 human CREB
synthetic peptide C R D A S N H K R R E P V G Q D corresp. to 1719 1733 human activated Notch2
peptide C N A A E R T P S H S G H L Q corresp. to 2396 2409 Notch 2
peptide C E H P F L T P S P E S P D Q corresp. to 2507 2520 at the C-terminus of Notch 1
peptide V L L S R K R R R Q H G Q C corresp. to 1755 1767 the N-terminal sequence of the cleaved N intracellular domain (NICD).
synthetic peptide K A S R G N D R N R I V L P F S C corresp. to 110 125 Human Jagged1 coupled to KLH
synthetic peptide (A W H A P G D D L R P E A L C) corresp. to 121 134 human Delta4, coupled to KLH
fusion protein from 1 564 NMDA NR1
C- terminal fusion protein representing 1253 1391 rat NMDAR2A
C- terminal fusion protein representing 1253 1391 rat NMDAR2B
N-terminal fusion protein (17 kDa) representing 25 130 rat NMDAR2C
peptide V L L S R K R R R Q H G Q C corresp. to 1755 1767 the N-terminal sequence of the cleaved N intracellular domain (NICD).
synthetic peptide: C Q H S Y S S P V D N T P S H Q corresp. to 2488 2502 Notch1 intra
peptide C E H P F L T P S P E S P D Q corresp. to 2507 2520 at the C-terminus of Notch 1
synthetic peptide C R D A S N H K R R E P V G Q D corresp. to 1719 1733 human activated Notch2
peptide C N A A E R T P S H S G H L Q corresp. to 2396 2409 Notch 2
synthetic peptide (A W H A P G D D L R P E A L C) corresp. to 121 134 human Delta4, coupled to KLH
fusion protein of NR3A aa 780 914 from the extracellular III-IV loop
fusion protein containing 175 430 from the N-terminal region of GluR2.
synthetic peptide corresp. to 1116 1130 the rat mGluR1α coupled to bovine thyroglobulin with glutaraldehyde
fusion protein from 1 564 NMDA NR1
KLH conj. synthetic peptide corr. to 2542 2554 Notch1
KLH conj. synthetic peptide corr. to 2457 2471 human Notch2
KLH conj. synthetic peptide corr. to 2306 2321 human Notch3
KLH conj. synthetic peptide corr. to 1984 2002 human Notch4
KLH conj. synthetic peptide corr. to 1204 1218 human Jagged1
KLH conj. synthetic peptide corr. to 1224 1238 human Jagged2
1 290 human CREB-2
254 327 mapping within the DNA binding and dimerization domain of human CREB-1 p43
254 327 mapping within the DNA binding and dimerization domain of humrn CREB-1 p43
254 327 human CREB-1
303 478 mapping at the C-terminus of mouse CaMKIIα
1 300 mapping at the N-terminus of human CaMKIIα
303 478 mouse CaMKII
303 478 mouse CaMKIIα
20 150 mapping within an extracellular domain of human Notch 1
1779 2003 mapping at the C-terminus of mouse Notch 4
25 255 mapping within an extracellular domain of human Notch 2
2107 2240 mouse Notch 3
amino acid 1299 1492 (region EGF repeat 33 through LNG repeat 1) of mouse Notch 1
207 272 human Jagged
1110 1223 human Jagged
459 723 human Delta
1253 1391 , unconjugated
fusion protein encoding the putative extracellular N-terminal domain of GluR2 ( 170 430 )
448 468 at C-terminal of rat CaMKinase II α
448 460 at C-terminal of rat CaM Kinase IIα
448 460 at C-terminal of rat CaM Kinase IIα
fusion protein containing 1 564 the NR1-subunit of rat NMDA Receptor.
fusion protein from 1 564 NMDA NR1
peptide corresp. to 7 20 rat multi-functional CaMKinase II Δ isoform conjugated to KLH
recombinant human CREB ( 136 341 ) derived from E. coli
purified, NS0-derived, recombinant rat Notch-1 ( 20 488 )
purified, NS0-derived, recombinant rat Notch-2 ( 26 492 )
purified, NS0-derived, recombinant rat Notch-2 ( 26 492 )
purified, Sf21-derived, recombinant mouse Notch-3 ( 40 468 )
purified, Sf21-derived, recombinant mouse Notch-3 ( 40 468 )
purified, NSO-derived, recombinant human Jagged 1 ( 1 296 )
purified, NSO-derived recombinant human Jagged-1 ( 1 296 )
purified, NSO-derived recombinant human Jagged-1 ( 1 296 )
purified, NS0-derived, recombinant human Jagged 2 ( 27 307 )
purified, E. coli-derived, recomb. human CBP ( 2141 2442 )
synthetic peptide ( 7 20 ) from rat CaM kinase II, conj. to KLH
synthetic peptide ( 7 20 ) from rat CaM Kinase II, conj. to KLH
phospho peptide corresp. to 122 147 region of human CREB
peptide corresp. to 5 45 near the N-terminus of human CREB conjugated to KLH
synthetic peptide corresp. to 6 23 human CaMKinase II protein
synthetic peptide (V L L S R K R R R Q H G Q-C)corresp. to 1755 1767 human Notch-1 (NICD)
synthetic peptide (C-Q H S Y S S P V D N T P S H Q) corresp. to 2488 2502 human Notch1.
synthetic peptide (C-E H P F L T P S P E S P D Q) corresp. to aa 2507 2520 human Notch-1
synthetic peptide corresponding to aa 2396 2409 human Notch-2
synthetic peptide corresponding to 121 134 human Delta-4
synthetic peptide (C-G E E W S Q D L H S S G R T D L R Y S) corresp. to 155 173 mouse DELTA-1
synthetic peptide corresp. to aa 123 137 (K R R E I L S R R P S Y R K C) of human CREB, coupled to KLH
synthetic peptide (K W Q I V H F H R S G A P S V L P H) corresp. to the C-terminal 461 478 ) region of rat CaMKinase IIα
peptide phosphorylated at Thr286 (M H R Q E pT V D C L K K F N), corresp. to 281 294 rat and mouse CaM Kinase IIα subunit
synthetic peptide 918 938 corresp. to the C-terminus of rat NMDAR1 conjugated to KLH
1253 1391 from the C-terminal portion of NMDA2A (NR2A)
synthetic peptide corresp. to 1449 1464 at the C-terminus of rat NMDAR2A
984 1104 at C-terminus of NR2B
25 130 at N-terminal of NR2C
synthetic peptide (K W Q I V H F H R S G A P S V L P H) corresp. to C-terminal 461 478 ) of rat CaM Kinase IIα
recomb. protein containing 660 811 the NMDA R1 receptor
recomb. protein containing 660 811 the NMDA R1 receptor
synthetic peptide corresp. to 100 150 human CREB
synthetic peptide corresp. to 281 288 conjugated to KLH
purified, NSO-derived, recombinant human Jagged-2 ( 27 307 )
14 residue synthetic peptide CTRFTDEYQLFEEL based on rat multifunctional calmodulin dependent kinase II delta isoform ( 7 20 ) coupled to KLH.
synthetic peptide corresp. to 100 150 human CREB
phospho peptide corresp. to 122 147 region of human CREB
254 327 mapping within the DNA binding and dimerization domain of humrn CREB-1 p43
254 327 human CREB-1
peptide corresp. to 5 45 near the N-terminus of human CREB conjugated to KLH
254 327 mapping within the DNA binding and dimerization domain of human CREB-1 p43
1 290 human CREB-2
14 residue synthetic peptide CTRFTDEYQLFEEL based on rat multifunctional calmodulin dependent kinase II delta isoform ( 7 20 ) coupled to KLH.
303 478 mouse CaMKII
1 300 mapping at the N-terminus of human CaMKIIα
303 478 mapping at the C-terminus of mouse CaMKIIα
303 478 mouse CaMKIIα
synthetic peptide based on sequence from rat/mouse CaMKIIa ( 281 294 ), thio phosphorylated at auto phosphorylation residue Thr-286, conjugated
synthetic peptide based on sequence from rat/mouse CaMKIIa ( 281 294 ), thio phosphorylated at auto phosphorylation residue Thr-286, conjugated
synthetic peptide (V L L S R K R R R Q H G Q-C)corresp. to 1755 1767 human Notch-1 (NICD)
synthetic peptide (C-Q H S Y S S P V D N T P S H Q) corresp. to 2488 2502 human Notch1.
synthetic peptide (C-E H P F L T P S P E S P D Q) corresp. to aa 2507 2520 human Notch-1
synthetic peptide corresponding to aa 2396 2409 human Notch-2
amino acid 1299 1492 (region EGF repeat 33 through LNG repeat 1) of mouse Notch 1
20 150 mapping within an extracellular domain of human Notch 1
25 255 mapping within an extracellular domain of human Notch 2
2107 2240 mouse Notch 3
1779 2003 mapping at the C-terminus of mouse Notch 4
914 1056 human Jagged2
19 318 within an extracellular domain of human NMDAζ1
23 76 within an extracellular domain of human NMDAε1
27 76 within an extracellular domain of human NMDAε2
268 386 human NMDAε4
268 386 corr. to an internal region of human NMDAε4
19 318 within an extracellular domain of human NMDAζ1
23 76 within an extracellular domain of human NMDAε1
27 76 within an extracellular domain of human NMDAε2
268 386 corr. to an internal region of human NMDAε4
synthetic peptide (VAKNPQNIN PSSSQNS) corr. to 827 842 from the C-terminus of rat GluR2
6His-tagged fusion protein corresponding to 7 305 ferret CaM Kinase II γ-subunit
synthetic thiophos-phated (Thr286) peptide corresp. to 281 294 from the α-subunit of mouse and rat CaM kinase II
synthetic peptide corresponding to 125 135 CREB phosphorylated at Ser133
synthetic peptide corresponding to 6 23 human CREB-1
synthetic peptide corresponding to 6 23 human CREB-1
peptide corresp. to 5 45 near the N-terminus of human CREB conjugated to KLH
synthetic peptide corresponding to 123 136 human CREB
synthetic phospho-peptide corresponding to 123 136 human CREB
phospho peptide corresp. to 122 147 region of human CREB
synthetic peptide corresponding to 125 135 CREB phosphorylated at Ser133
synthetic peptide based on sequence from rat/mouse CaMKIIa ( 281 294 ), thio phosphorylated at auto phosphorylation residue Thr-286, conjugated
synthetic phospho-peptide corresponding to 123 136 rat CREB coupled to KLH
CREB-1 (p43) peptide corresponding to the N-terminal 5 45 human protein conjugated to KLH
phosphorylated (Thr286) peptide corresponding to 281 294 (M H R Q E T V D C L K K F N) of the mouse/rat CaM kinase II α subunit
synthetic peptide corresp. to 6 23 human CaMKinase II protein
synthetic peptide selected within 400 478 human CAMK2α
synthetic peptide selected within 500 550 human CAMK2β.
synthetic peptide selected from 397 411 human CAMK2γ.
synthetic peptide selected within 450 499 human CAMK2δ
synthetic peptide selected from 324 338 human CAMK2 δ-like
rat CaMK II synthetic peptide ( 7 20 ), conjugated to KLH
synthetic peptide corresponding to 281 294 rat CaM Kinase II α-subunit
synthetic peptide (KMHRQE[pT]VDCLK) correspond. to 281 291 rat CaM Kinase II α-subunit
synthetic peptide corresponding to 281 294 rat CaM Kinase II α-subunit
rat CaMK II synthetic peptide ( 7 20 ), conjugated to KLH
synthetic peptide (KMHRQE[pT]VDCLK) correspond. to 281 291 rat CaM Kinase II α-subunit
synthetic peptide based on sequence from rat/mouse CaMKIIa ( 281 294 ), thio phosphorylated at auto phosphorylation residue Thr-286, conjugated
synthetic phospho-peptide corresp. to 826 836 mature GluR1 from mouse and rat
synthetic peptide corresp. to 840 850 the mature chain, with a phosphorylated serine at position 845.
recomb. fusion protein TrpE-GluR2 (N-terminal portion, 175 430 rat GluR2)
synthetic peptide from 827 842 , of rat GluR2 conj. to BSA through a cysteine added to the C-terminus
C-terminal synthetic peptide sequence corresponding to 894 907 rat GluR1 coupled to bovine thyroglobulin with glutaraldehyde
synthetic phospho-peptide corresponding to 891 902 rat NMDA receptor subunit NR1
synthetic phospho-peptide corresp. to 891 902 rat NMDA receptor subunit NR1
fusion protein containing 1 564 rat NMDA NR1
fusion protein from 1 564 rat NMDA NR1
fusion protein containing 984 1104 NMDAR 2B subunit
fusion protein containing 1253 1391 NMDAR 2A-subunit
a 17 kDa fusion protein constructed from the N-terminal region 25 130 the rat NMDAR 2C subunit
synthetic peptide (C-E H P F L T P S P E S P D Q) corresp. to aa 2507 2520 human Notch-1
synthetic peptide (V L L S R K R R R Q H G Q-C)corresp. to 1755 1767 human Notch-1 (NICD)
synthetic peptide (C-Q H S Y S S P V D N T P S H Q) corresp. to 2488 2502 human Notch1.
synthetic peptide corresponding to aa 2396 2409 human Notch-2
GST-fusion protein containing 1299 1492 mouse Notch 1
GST-fusion protein corresponding to aa 381 853 rat Notch 1
GST-fusion protein corresponding to aa 2272 2488 rat Notch 1
His-tag fusion protein containing the C-terminus 5708 6217 murine Notch 4
GST fusion protein corresponding to 2272 2488 rat Notch 1
His-tag fusion protein containing the C-terminus 5935 6454 murine Notch 3
GST fusion protein comprising 1299 1492 mouse Notch 1
synthetic peptide 10 30 aa in length) at the C-term of last 50 aa of human Jag1
synthetic peptide 10 30 aa in length) of last 50 aa at the C-term of human Jag2
fusion protein containing aa 1253 1391 C-terminal of rat brain subunit 2A
fusion protein containing aa 984 1104 C-terminal of rat brain subunit 2B
fusion protein containing aa 25 130 N-terminal of rat brain subunit 2C
full length bovine brain protein. Epitope 1 151
full length bovine protein. Epitope 997 1332
synthetic peptide: P K K K P T P I Q L N P corresp. to 1 12 MEK1 with a terminal cysteine, coupled to KLH
Synthetic peptide: (C)Y N H R T D L F K S F P G P, corresp. to 590 603 human ADAMTS4, with N-terminally added cysteine
synthetic peptide: K N G Y Q S D A K G V K T F, corresp. to 636 649 human ADAMTS5 with N-terminally added cysteine.
two synthetic peptides, conjugated to KLH, derived from within 1 50 and 450-610 of human SIRT1
synthetic peptide: A T R Q E L T D V N Y P S D K S (with C-terminal added lysine), corresp. to C terminal 722 737 mouse SIRT1
synthetic peptide 10 30 aa in length) at the N-term of first 50 aa of human MAP2, KLH conjugated
synthetic peptide 10 30 aa in length) at the C-term of last 50 aa of human MAP2
synthetic peptide 10 30 aa in length) in the region of 302~318 of human MAP4K2, KLH conj.
synthetic peptide selected from the sequence of human MAPK10 within 1 100 , KLH conj.
synthetic peptide selected from the sequence of human MAPK11 within 300 400 , KLH conj.
synthetic peptide selected from the sequence of human MAPK12 within 300 400 , KLH conj.
synthetic peptide selected from the sequence of human MAPK13 within 300 400 , KLH conj.
synthetic peptide selected from the sequence of human MAPK14 within 200 300 , KLH conj.
synthetic peptide selected from the sequence of human MAPK8 within 200 300 , KLH conj.
synthetic peptide selected from the sequence of human MAPK9 within 200 300 , KLH conj.
synthetic peptide selected from the sequence of human MAP2K1 within 1 100 , KLH conj.
synthetic peptide selected from the sequence of human MAP2K2 within 1 100 , KLH conj.
synthetic peptide selected from the sequence of human MAP2K6 within 1 100 , KLH conj.
synthetic peptide selected from the sequence of human MAP2K6 within 250 350 , KLH conj.
synthetic peptide selected from the sequence of human MAP3K9 within 300 400 , KLH conj.
synthetic peptide selected from the sequence of human MAP3K9 within 1 100 , KLH conj.
synthetic peptide 10 30 aa in length) at the C-term of last 100 aa of human Sirt1, KLH coupled
C-terminus
( 343 358 )
( 351 368 )
N-terminus
( 87 99 )
synthetic peptide C-T Y D E V I S F V P P P L D Q E E M E S based on the human p38 ( 341 360 ), coupled to KLH (sequence identical to mouse)
synthetic peptide: C A A G P E M V R G Q V F corresp. to 9 19 human ERK2
synthetic peptide C S A Y D A R L R Q K V A V K corresp. to 39 53 human MAPK11
recombinant fragment, corresp. to 232 360 human ERK2
A 12 residue synthetic peptide A A G P E M V R G Q V F (C) based on the rat ERK2 ( 6 17 ), coupled to KLH
Synthetic peptide: C A A G P E M V R G Q V F, corresp. to 9 19 human ERK2
synthetic peptide (C) D R L T A E E A L S H P Y M, corresp. to 303 325 rat ERK3 with a added cysteine residue, coupled to KLH
synthetic peptide M A E P L K E E D G E D G S corresp. to N- terminal 1 14 human ERK5 coupled to KLH
synthetic peptide D E Q E A L D S I M K D L V A L Q-C corresponding to 2 18 mouse MEKK3, conj. to KLH
synthetic peptide, corresp. to 334 349 ERK5
synthetic peptide corresp. to 350 400 human ERK1 conjugated to KLH
recombinant fragment, corresp. to 232 360 human ERK2
synthetic peptide H S S S E R F L E Q S H S S M E, corresp. to 401 416 human ERK3
synthetic peptide selected from the sequence of human MAP2K2 within 200 300 , KLH conj.
synthetic peptide derived from 317 339 within the C-terminal half of the human ERK1 protein.
synthetic peptide derived from aa 334 349 human ERK5/BMK1 protein
peptide derived from 317 339 human ERK1 (MAPK). Sequence conserved in human and rat.
synthetic peptide corresp. to 1356 1375 human ASK1
a 14 residue synthetic peptide A P G G G G G E P R G T A G (C) based on rat ERK1 MAP kinase ( 7 20 ) with an added cysteine and coupled to KLH
synthetic peptide selected from the sequence of human MAPK10 within 1 100 conj. to KLH
synthetic peptide selected from the sequence of human MAPK11 within 300 400
synthetic peptide selected from the sequence of human MAPK12 within 300 400 , conj. to KLH
synthetic peptide selected from the sequence of human MAPK13 within 300 400
synthetic peptide selected from the sequence of human MAPK14 within 200 300 conj. to KLH
synthetic peptide selected from the sequence of human MAPK8 within 200 300 conj. to KLH
synthetic peptide selected from the sequence of human MAPK9 within 200 300 conj. to KLH
a 35 residue synthetic peptide corresp. to 333 367 rat ERK1 MAP kinase with the CGG spacer group added, coupled to KLH
a 23 residue 303 325 ) synthetic peptide (C) D R L T A E E A L S H P Y M S I Y S F P T D E based on the rat ERK3 coupled to KLH
synthetic peptide selected within 1 50 human ERK1, conj. to KLH
synthetic peptide selected from 269 285 human ERK2
synthetic peptide selected from 707 721 human ERK3, coupled to KLH
synthetic peptide slected from 542 557 human ERK4
synthetic peptide 10 30 aa in length) at the N-term of first 50 aa of human MAP2, KLH conjugated
synthetic peptide 10 30 aa in length) at the C-term of last 50 aa of human MAP2
synthetic peptide from 1 13 rat MEK2 coupled to KLH
a 17 residue 2 18 ) synthetic peptide D E Q E A L D S I M K D L V A L Q(C) based on mouse MEKK3 with an added cysteine coupled to KLH
a 16 residue 59 74 ) synthetic peptide A F E Y E D E D G D R I T V R S(C) based on human and rat MEK5 with added cysteine and coupled to KLH
a 12 residue 1 12 )synthetic peptide M P K K K P T P I Q L N(C) coupled to KLH
a 15 residue 320 334 ) peptide (C)K G T D V A S F V K L I L G D based on human MEK6 with an added cystein and coupled to KLH
a 26 residue 654 669 ) synthetic peptide (C)Q D R P P S R E L L K H P V F R based on murine MEK kinase with an added cysteine and coupled to KLH
synthetic peptide selected from 1 17 human MEK1
synthetic peptide selected from 1 17 human MEK2 conjugated to KLH
synthetic peptide selected from 425 438 human MEK
synthetic peptide selected from 1143 1159 human MEKK1
synthetic peptide selected from 138 153 human MEKK2 conj. to KLH
synthetic peptide selected from 124 141 human MEKK3
synthetic peptide selected from 1081 1097 human MEKK4
synthetic peptide selected from 1282 1297 human MEKK5
synthetic peptide selected from 765 781 human MEKK6
synthetic peptide selected from 428 445 human MEKK8 conj. to KLH
KLH conjugated peptide corr. to 76 87 human ASK-1 protein.
peptide sequence corresp. to 1356 1375 human ASK1
synthetic peptide: E E K D Q E I K H L K L K S Q P corresp. to 1276 1291 ASK1 with C-terminally added cysteine coupled to KLH
peptide corresp. to 76 87 human ASK-1 protein conj. to KLH
peptide corresp. to 1356 1375 human ASK1
synthetic peptide 10 30 aa in length) at the C-term of last 100 aa of human Sirt1, KLH coupled
synthetic peptide corresponding to positions 325 345 the intact MAP kinase
764 837 human ADAMTS-4
peptide corresp. to 333 367 rat ERK1 conj. to KLH
1 300 mapping at the N-terminus of human MAP-2
2211 2510 human MAP-1A
2221 2350 human MAP-1B
1 50 mapping at the N-terminus of human MAP-1A light chain 3
997 1332 bovine high molecular weight MAP-2 isoforms
peptide corresp. to 1 28 human MAP2K1
37 92 mapping at the C-terminus of human S-100 β chain
448 747 human SIRT1
565 721 mapping at the C-terminus of human ERK3
416 815 mapping at the C-terminus of human ERK 5
229 318 mapping at the C-terminus of human MEK-3/6
302 399 mapping at the C-terminus of human MEK-4
351 444 mapping at the C-terminus of human MEK-5
1 160 mapping at the N-terminus of human MEK-7
1 160 human MEK-7
1076 1375 human ASK1
1076 1375 human ASK1
2211 2510 human MAP-1A
2221 2350 human MAP-1B
997 1332 bovine high molecular weight MAP-2 isoforms
1 300 mapping at the N-terminus of human MAP-2
1 50 mapping at the N-terminus of human MAP-1A light chain 3
37 92 mapping at the C-terminus of human S-100β
1 154 representing full length human SOD-1
1 154 human SOD-1
1 222 representing full length human SOD-2
1057 1178 mapping near the C-terminus of human SOS 1
1057 1178 mapping near the C-terminus of human Sos 1
339 353 rat ERK1
synthetic peptide (C G G P F T F D M E L D D L P K E R L K E R L K E I F Q E T A R F Q P G A P E A P) corresp. to 333 367 rat ERK1 MAP kinase plus CGG spacer group and coupled to KLH
synthetic peptide (A A G P E M V R G Q V F C) corresp. to 6 17 rat ERK2, with a cysteine (C) added and coupled to KLH
synthetic peptide (H A F I K R S D A E E V D F A G W L C) corresp. to 359 377 human MEK1 coupled to KLH
synthetic peptide (M P K K K P T P I Q L N C) corresp. to 1 12 rat MEK1 with cysteine (C) added and coupled to KLH
synthetic peptide corresp. to 59 74 human and rat MEK5 with an added cysteine (C)and coupled to KLH
synthetic peptide (T Y D E Y I S F V P P P L D Q E E M E S) corresp. to 341 360 p38 MAP kinase
synthetic peptide (G R L V D S K A K T R S A G C) corresp. to 266 280 human MKK7
peptide corresp. to 1243 1258 (K K S D H G N A F F P N S P S P) of murine Son of Sevenless Homolog 1 Protein (SOS 1)
peptide corresp. to 551 599 human Sirt1
peptide corresp. to 1356 1375 human ASK1
synthetic peptide derived from 317 339 within the C-terminal half of human ERK1 protein
N-terminal 11 28 ERK-1
232 360 from human ERK-2
401 416 human ERK-3
N-terminus 2 140 human ERK5
N-terminal 341 570 human ERK-5
amino acid 1 28 MAP2K1
997 1332 of MAP2
213 360 p38 of human origin
213 360 p38 of human origin
amino acids 281 360 mapping within an internal region of MEK kinase-2 of human origin
amino acids 291 360 mapping within an internal region of MEK kinase-3 of human origin
amino acids 1531 1607 mapping at the C-terminus of MEK kinase-4 of human origin
1 393 representing full length MEK-1 of human origin
a peptide corresp. to 1360 1372 human ASK1
a synthetic peptide (RGGMLCTLW KAIIDFRNKQT)corresp. to 1356 1375 human ASK1